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Abstract 
The Ph.D. project has been structured in three different parts: 
The first one focused on setting up and characterizing a 70/30 Caco2/HT-29 co-culture as an in 
vitro model to mimic the physiology of the human intestinal epithelium starting from the two 
parental cell populations already differentiated. The co-culture morpho-functional features 
were analyzed at confluence (T0) and 3, 6, 10 and 14 days after T0 (T3, T6, T10 and T14, 
respectively). Morphological analysis revealed: at T6, the presence of microvilli, a complete 
paracellular junctional apparatus and mucus; at T14, abundant microvilli and mucus absence. 
The functional analysis showed: an increase of Alkaline Phosphatase, Aminopeptidase N and 
Dipeptidyl Peptidase IV specific activity with days in culture, indicative of a progressive 
acquisition of a differentiated intestinal phenotype; permeability values comparable to the ones 
of the human small intestine and indicative of a good status of the tight junctions. This co-
culture could be considered a more versatile, suitable and simpler in vitro model of human small 
intestinal epithelium, than the previous published ones, able to reach the intestinal differentiated 
phenotype already after six days from the confluence. 
The second part focused on the validation of the 70/30 Caco2/HT-29 co-culture as model to 
study absorption and nutrient/food-intestine interactions at molecular and biochemical level. 
Five different experimental water biscuits and breads were subjected to an in vitro 
gastrointestinal digestion and the obtained digestates were administered to the co-culture at 
physiological doses, calculated starting from the daily recommended dose in relation to the total 
surface area of intestinal absorption, and in excess. The effect of digestates administration on 
co-culture cell viability, paracellular permeability, oxidative status and anorectic hormones 
production were evaluated: all the digestates were not able to affect co-culture viability or to 
modify the paracellular permeability; all the water biscuit digestates were able to reduce 
intracellular ROS formation due to the natural presence of antioxidant compounds in the flours 
used to prepare them; all the bread samples were able to modulate the co-culture anorectic 
hormone production. These studies showed the suitability of the co-culture to study a wide 
range of interactions between nutrients/food/nutraceuticals and intestine. 
The third part focused on setting up and characterizing an in vitro cellular model of 
obese/overweight intestine using the 70/30 Caco2/HT-29 co-culture. The nutrient excess was 
mimed increasing the frequency of medium change compared to the standard condition and the 
co-culture morpho-functional features were analyzed at 3, 7, 11 and 15 days after confluence 
(T3, T7, T11 and T15, respectively). The obtained in vitro model, after 15 days of post-
confluence and compared to our standard co-culture, showed a higher: i) inflammatory and 
oxidative status; ii) paracellular permeability; iii) microvilli enzyme activity; iv) production of 
anorectic hormones. These features were comparable to the ones revealed in vivo in the intestine 
of obese subjects, thus validating the present cellular model to study obesity-associated 
modifications at the molecular level. 
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Riassunto 
Il progetto di dottorato è stato strutturato in tre parti: 
La prima parte è stata focalizzata sulla messa a punto e sulla caratterizzazione di una co-coltura 
70/30 Caco2/HT-29 come modello in vitro per mimare la fisiologia dell'epitelio intestinale 
umano a partire dalle due popolazioni di cellule parentali già differenziate. Le caratteristiche 
morfo-funzionali della co-coltura sono state analizzate alla confluenza (T0) e dopo 3, 6, 10 e 
14 giorni (T3, T6, T10 e T14, rispettivamente). L'analisi morfologica ha rivelato: a T6, la 
presenza di microvilli, un apparato giunzionale completo e muco; a T14, abbondanti microvilli 
e assenza di muco. L'analisi funzionale ha mostrato: un progressivo aumento dell'attività 
specifica di fosfatasi alcalina, amino peptidasi N e dipeptidil peptidasi IV, all’aumentare dei 
giorni in coltura, indicativo di una progressiva acquisizione di un fenotipo intestinale 
differenziato; valori di permeabilità paragonabili a quelli dell'intestino tenue umano e indicativi 
di un buono stato delle giunzioni strette. Questa co-coltura può essere considerata un modello 
in vitro più versatile, idoneo e semplice per mimare l'epitelio dell'intestino tenue umano, rispetto 
a quelli pubblicati in precedenza, ed in grado di raggiungere il fenotipo intestinale differenziato 
già dopo sei giorni dalla confluenza. 
La seconda parte si è incentrata sulla validazione della co-coltura 70/30 Caco2/HT-29 come 
modello per studiare l’assorbimento e le interazioni nutrienti/cibo-intestino sia a livello 
molecolare che biochimico. Cinque diversi campioni di biscotti e pane sperimentali sono stati 
sottoposti a digestione gastrointestinale in vitro e i digeriti ottenuti sono stati somministrati alla 
co-coltura a dosi fisiologiche, calcolati a partire dalla dose giornaliera raccomandata in 
relazione alla superficie totale di assorbimento intestinale, e in eccesso. Sono stati valutati gli 
effetti della somministrazione dei digeriti sulla vitalità della co-coltura, sulla permeabilità 
paracellulare, sullo stato ossidativo e sulla produzione di ormoni anoressizzanti: tutti i digeriti 
non sono stati in grado di influenzare la vitalità della co-coltura o di modificare la permeabilità 
paracellulare; tutti i digeriti di biscotti sono stati in grado di ridurre la formazione di ROS 
intracellulari grazie alla presenza naturale di composti antiossidanti nelle farine utilizzate per 
la loro preparazione; tutti i campioni di pane sono stati in grado di modulare la produzione di 
ormoni anoressizzanti. Questi studi hanno dimostrato, tra gli altri risultati, anche l'idoneità della 
co-coltura per studiare un'ampia gamma di interazioni tra nutrienti/alimenti/nutraceutici ed 
intestino. 
La terza parte è stata focalizzata sulla messa a punto e sulla caratterizzazione di un modello 
cellulare in vitro d’intestino tipico di soggetti obesi/in sovrappeso partendo dalla co-coltura 
70/30 Caco2/HT-29. L'eccesso di nutrienti è stato mimato aumentando la frequenza del cambio 
medium rispetto alle condizioni standard e le caratteristiche morfo-funzionali della co-coltura 
sono state analizzate a 3, 7, 11 e 15 giorni dopo la confluenza (T3, T7, T11 e T15, 
rispettivamente). L’eccesso di nutrienti dopo 15 giorni di post-confluenza, confrontato con la 
co-coltura standard, ha mostrato un più alto: i) stato infiammatorio e ossidativo; ii) permeabilità 
paracellulare; iii) attività specifica degli enzimi dei microvilli; iv) produzione di ormoni 
anoressizzanti. Queste caratteristiche sono paragonabili a quelle evidenziate in vivo 
nell'intestino di soggetti obesi, convalidando così la co-coltura sottoposta a un eccesso di 
nutrienti mediante aumento della frequenza di cambio medium, come modello cellulare per 
studiare a livello molecolare le modificazioni intestinali associate all'obesità. 
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General introduction 
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1.1 In vitro cell models of human intestinal epithelium 
Intestine is the first part of our body that is exposed to exogenous substances such as food, 
drugs and microorganisms. Currently, the procedures for keeping primary intestinal cells in 
culture are not able to create stable cell cultures that maintain the original tissue phenotype for 
a long period. For this reasons, the study of nutrients absorption, transport and their interactions, 
at the molecular level, with the intestine requires the development of adequate in vitro human 
intestinal models [1]. Among these, the human adenocarcinoma Caco2 and HT-29 cell lines [2, 
3], that when differentiated show enterocyte or mucus-secreting features, represent the main in 
vitro gut models used for studying the biological mechanisms and functions of the intestinal 
mucosa [1, 4]. However, these models have several limitations when compared with the 
morpho-functional characteristics of the in vivo human intestinal epithelium:  
Caco2 
The Caco2 cell line is characterized by the ability to spontaneously undertake a differentiation 
process towards the absorbent cell phenotype, forming a polarized monolayer with different 
characteristics typical of the human small intestinal enterocytes: apical brush border with active 
hydrolytic enzymes, a complete paracellular junctional apparatus and specific nutrient 
transports at the membrane level [1, 5]. This process depends on long post-confluence, passage 
number [6-8], growth support and the presence of Fetal Bovine Serum (FBS), glutamine and 
glucose concentration in the culture medium [9-11]. The intestinal model composed only by 
Caco2 cells share different important features with the human intestinal epithelium but, at the 
same time, it is composed only by absorbent enterocytes, which are tightly connected to each 
other by tight junctions, leading to a considerable reduction in the monolayer permeability 
compared to the intestinal physiological one [12, 13]. Furthermore, the epithelium of the small 
intestine is composed by different cell types, such as the mucus secreting Goblet cells, which 
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are important for the mucus barrier production and, as a consequence, of the intestinal 
epithelium protection, but absent in this model. The low intestinal permeability associated with 
the absence of mucus makes the in vitro Caco2 model unable to fully represent the human 
intestinal epithelium. 
HT-29 
The HT-29 cell line is not able to spontaneously undertake a differentiation process towards the 
enterocytic phenotype but it must be inducted by a low glucose concentration in the growth 
medium [14-17] and/or treatment with differentiation inducers, such as sodium butyrate, or 
specific drugs (Forskolin, Colchicine, Nocodazole or Taxol) [18, 19]. Under these conditions, 
this cell line is able to form a discontinuous monolayer with a well-developed brush border and 
a complete paracellular junctional apparatus [16, 20]. This cell line has also the ability to create 
clones and sub-clones with the typical characteristics of mucus secreting cells [21, 22]. 
However, these cells are unable to form a continuous monolayer and present tight junction with 
a permeability higher than the human small intestine physiological one [20, 22, 23]. 
The limitations of this two intestinal cell lines has driven to the to the development of co-culture 
models, composed by different proportion of Caco2 and HT-29 cell lines, more suitable to 
represent in vitro the morphology and permeability of the human intestinal epithelium. These 
co-culture models, fundamental to obtain in the same culture both the absorptive and the mucus 
secreting cells, were obtained as follows: i)  using HT-29 mucus secreting sub-clones, such as 
HT29-MTX, HT29-H and HT29-5M21 [22-27]; ii) adapting the two cell lines to growth 
conditions different from the standard ones, such as the absence of FBS or varying not only the 
proportions of the two cell types but also the timing of seeding  [13, 28]; iii) using 3D cultures 
[29]. These co-culture models, despite mimicking at best the morpho-functional characteristics 
of the in vivo intestinal epithelium, needs a lot of time to be ready for an experimental procedure 
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and, in most cases, it is difficult to understand whether the acquired differentiated phenotype is 
due to the sub-clones presence or the used growth medium. 
1.2 Food-derived bioactive compounds 
In the last few years, research showed an increased interest in food, both from animal and plant 
origin, as a source of health-promoting bioactive substances. These can be defined as “food 
components that can affect biological processes or substrates and, hence, have an impact on 
body function or condition and ultimately health” [30]. So, bioactive food components must 
show an assessable biological effect when utilized in doses comparable to the physiological one 
normally assumed with daily food ingestion [30]. Among these substances, the most studied 
were bioactive peptide, phenolic compounds and carotenoids. 
1.2.1 Bioactive peptides  
Nutritionally, proteins are an essential source of amino acids but, in the last twenty years, other 
in vivo functionalities with a positive impact on human health have been attributed to dietary 
proteins. These proprieties were exerted by peptides that are inactive when enclosed in the 
native protein and can be released by gastrointestinal digestion, activity of proteolytic 
microorganism, food processing and ripening [30, 31]. Milk and dairy products were the most 
important sources of these peptides together with meat, eggs, fishes as well as bovine blood, 
gelatin, cereals, pseudocereals and legumes [30-33]. These bioactive peptides are usually 
sequences composed by 2-20 amino acids residues, but also few peptides with more than 20 
residues have been shown to exert biological activities [32]. Bioactive peptides, once formed, 
can exert a wide range of functions with a positive impact on human body physiology and 
health, and some of them can induce more than one positive effect.  
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These properties were deeply reviewed in different papers [30-33] and include: 
Opioid activity  
Opioid peptides with agonist or antagonist activity are able to bind opioid receptors present 
both at the level of central nervous system and in many other tissues and organs [31, 33]. Among 
foods, milk is one of the most important source of opioid peptides. These are able to positively 
modulate gastrointestinal functions as follows: increasing the time necessary for food 
gastrointestinal transit, modulating amino acids transport, reducing the diarrhea onset and 
inducing insulin and somatostatin production after a meal [34]. Furthermore, they can modify 
social behavior and induce analgesia acting at the cerebral level [34]. The most studied milk-
derived opioid peptides are β-casein derived fragments, named β-casomorphins, but also α- and 
β-lactorphin share the same opioid agonist behavior [34]. 
Antihypertensive activity 
A wide range of bioactive peptides from animal and plant origin is able to inhibit the 
angiotensin-converting enzyme (ACE) preventing from hypertension development. This 
enzyme controls the arterial vasoconstriction by the conversion of angiotensin I in angiotensin 
II (vasoconstrictor) and inhibition of bradykinin (vasodilator) [30]. Peptides able to inhibit ACE 
enzyme lead to a blood pressure decrease and, as a consequence, to an antihypertensive effect 
[30-32, 34]. In addition, also opioid peptides can modulate blood pressure acting on the opioid 
receptors in the nervous system and in peripheral tissues [35].   
Antioxidant activity 
Cells oxidative metabolism is essential for cell survival, but when an exogenous molecule or 
environmental factors induce a production of both free radicals and non-radical oxidative 
species (ROS and NO) in excess compared to the antioxidant cell capacity protection, this could 
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lead to lethal modification of cell macromolecules: oxidations of proteins, membrane lipids and 
DNA. 
Plant and animal derived food contains many proteins that have encrypted bioactive peptides 
and amino acids with antioxidant capacity. Soybean hydrolysates contain different tripeptides 
mainly composed by His, Tyr, Pro and Trp with a strong radical scavenging activity [36, 37]. 
Also peptides from other vegetable sources, such as wheat germ proteins or gliadin and pea, are 
a source of antioxidant peptides [38-40]. Lunasin, a peptide found in soybean, cereals and 
pseudocereals, shows an in vitro antioxidant activity due to its ability to chelate Fe2+ and 
therefore reducing the Fenton reaction onset [41]. The same chelating activity was revealed in 
vitro for the milk derived caseinophosphopeptides (CPP) [42] that also exert a radical 
scavenging activity [43]. Other milk peptides, derived from α-casein, act as antioxidants both 
by lipid peroxidation inhibition and by free radical scavenging activity. Furthermore, several 
antioxidant peptides derive from meat, fish or egg enzymatic digestion [31].  
Mineral-binding activity 
CPP are the most studied milk derived peptides for their capacity to bind bi- and trivalent ions 
(such as Ca2+ and Fe2+) due to the presence of the acid motif -Ser(P)-Ser(P)-Ser(P)-Glu-Glu- 
[44]. It has been demonstrated that in vitro CPP are able to chelate Ca2+ and increase the 
absorption of this ion at intestinal and bone level [45, 46]. Furthermore, they are able to promote 
osteoblast differentiation and mineralization [47]. Also peptides derived from porcine plasma 
and fish showed a calcium binding activity [31].  
Antimicrobial activity 
Microorganisms, animals and plants are an important source of bioactive peptides that are able 
to induce an inhibitory growth effects towards a wide range of pathogen bacteria, fungi, virus 
and parasites. The difference among these peptides is that the ones produced by animal proteins 
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are effective towards a wide range of pathogens while the ones produced by bacteria displayed 
a more specific action [31]. Also in this case, milk is the most important source of antimicrobial 
peptides [48]. Among these lactoferricin, a fragment derived from the whey protein lactoferrin, 
is the most studied due to its ability to increase the bacterial membrane permeability forming 
ion channels at the membrane level [34]. 
Immunomodulatory activity 
Bioactive peptides derived from animal and plant source are able to modulate in vitro the 
specific immune system. For example, peptides isolated from soybean hydrolysates showed a 
phagocytosis-stimulating activity [36]. Milk is an important source of immunomodulatory 
peptides that can modulate lymphocyte proliferation in vitro, reduce the production of cytokine 
involved in the immune system regulation and stimulate macrophages phagocytosis activity 
[30, 31, 34].   
Anticancer and cytomodulatory activity 
Different bioactive peptides from plant origin displayed the ability to reduce in vitro the 
proliferation of different cancer cell models. Among them the most studied were lunasin, 
peptides from rice, lectin and other bioactive peptides from legumes [36]. Anticancer activity 
was showed also by milk, goat and bovine meat derived peptides, but only the milk ones, for 
example CPP, can reduce proliferation and increase apoptosis in cancer cells [31, 49, 50]. 
1.2.2 Phenolic acids, flavonoids, tocols and carotenoids 
In the last years, different clinical and epidemiological studies focused the attention on the 
consumption of fruit and vegetables rich in antioxidants such as carotenoids, tocols, phenolic 
acids and flavonoids. Dietary guidelines recommended the daily consumption of these foods 
rich in biological active phytochemicals because are correlated to a protective effect against 
chronic diseases and cancer due to their ability to reduce oxidative stress and ROS formation. 
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ROS were normally produced by cell metabolism, but our lifestyle and diet could modify the 
ROS presence in our body inducing cell damages that leads to chronic diseases onset [51]. 
Therefore, the potential of plant as a fundamental source of antioxidants to protect human health 
against various diseases induced by free radicals has been deeply studied. 
 
Figure 1 | Role of antioxidants in the chronic diseases prevention [51]. 
Phenolic antioxidants 
Phenolic antioxidants are characterized by the presence of almost one aromatic ring with one 
or more hydroxylic groups [52] and were usually divided in Synthetic and Natural compounds. 
The natural ones were usually classified in flavonoids and non-flavonoids (Fig. 2). 
The main sources of phenolic compounds are beverages, fruit, vegetables and legumes and their 
multiple potential antioxidant mechanisms seem to be the free radicals scavenging, metal 
chelation and stabilization of hydroperoxides into hydroxyl derivatives. Furthermore, the 
simultaneous presence of different phenolic compounds combined with other reducing natural 
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molecules increase their antioxidant activity [53]. Among others, flavonoids were the most 
studied for their potential beneficial effects on human health.  
Figure 2 | Classification of phenolic antioxidants [53] 
Phenolic acids 
Phenolic acids can be divided into two groups: hydroxybenzoic acids and hydroxycinnamic 
acids derived from benzoic and cinnamic acid, respectively [54]. The principal antioxidant 
mechanism is due to radical scavenging by hydrogen atom donation. Among others, the 
phenolic acids with the highest dietary significance are gallic, caffeic, ferulic and p-coumaric 
[52, 54]. 
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Figure 3 | Phenolic acids and related compounds [53] 
Phenolic acids health-protective effects also include: antimutagenic, anticarcinogenic, anti-
inflammatory and antimicrobial [53, 54]. 
Flavonoids 
Flavonoids comprise the most studied groups of polyphenols. These compounds shared the 
same basic structure consisting of two aromatic rings connected by a three-carbon atoms bridge 
(C6-C3-C6). Differences in the aglycones C ring structure classify flavonoids into seven groups 
(Fig. 4): flavones, flavanones, flavonols, flavanonols, isoflavones, flavanols (catechins) and 
anthocyanidins [52, 55, 56]. The flavonoids antioxidant ability depends on the molecular 
structure of these compounds: i) the metal-chelating ability is strongly influenced by hydroxyls 
and carbonyl group arrangement, while ii) the scavenging activity depends on the hydrogen-
/electron-donating substituents presence. The antioxidant activity might include synergistic 
effects and usually the highest is the hydroxyl groups presence the highest is their antioxidant 
capacity [53]. 
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Figure 4 | Structure of different classes of flavonoids [55] 
Overall, flavonoids exert a wide range of pharmacological properties acting on the oxidative 
stress reduction: i) anti-inflammatory; ii) anticarcinogenic, inhibiting tumor cells proliferation; 
iii) antiviral and antibacterial; iv) anti-thrombogenic and anti-atherogenic, reducing LDL 
oxidation. They have also a protective effect against: i) obesity, diabetes and metabolic 
disorders, reducing glucose absorption at the gut and other tissues level; ii) bone, muscle and 
neurodegenerative diseases, preventing macromolecules oxidation. [52, 53, 55, 56] 
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Figure 5 | Representative natural flavonoids and their dietary sources. (A) flavones, (B) flavonols, (C) 
flavanols, (D) flavanones, (E) isoflavones, (F) anthocyanidins [55]  
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Tocols 
Tocols, also known as Vitamin E family, is a group of lipid-soluble compounds that consist in 
α-, β-, γ- and δ-tocopherols and the relative four tocotrienols, but the most important one as a 
source of Vitamin E for humans is α-tocopherol. The major sources of tocols were seeds and 
their derived oils, but also few vegetables and cereals. 
Figure 6 | Tocopherols and tocotrienols structure [53] 
Their antioxidant activity is mainly based on the lipid peroxyl radical scavenging and singlet 
oxygen quenching. Tocols and in particular tocopherols antioxidant activity was correlated to 
a protective effect against cardiovascular diseases, preventing LDL oxidation, and cancer 
development, inhibiting proliferation and enhancing apoptosis of tumor cells [53, 57, 58]. An 
adequate intake of these compounds was also correlated with the prevention of obesity, diabetes 
neurodegenerative and skin pathologies onset [57, 58]. 
Carotenoids 
Carotenoids are a family of fat-soluble compounds responsible for the yellow-orange-red color 
of fruit, vegetables and green vegetables. In plants, they protect the photosynthetic pathway 
from damages induced by UV exposition [51]. The 80-90% of human carotenoid intake comes 
from fruit and vegetables. Among the 600 existing types of these compounds, the most present 
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in human blood and therefore the most studies for their potential benefits were β-carotene, β-
cryptoxanthin, α-carotene, lycopene, lutein and zeaxanthin [59, 60].  
Figure 7 | Structure of the sixth predominant carotenoids in human blood [61] 
Carotenoids are the major human source of compounds with pro-vitamin A activity but in the 
last years the attention was focused on their antioxidant capacity. Food processing, chopping 
and cooking increase the carotenoids bioavailability while their absorption, by passive or 
facilitate diffusion, is favorite by the presence of fats and bile acids. Once absorbed they are 
incorporated in lipoproteins and absorbed differentially at the level of human tissues [51, 60, 
61]. Carotenoids can reduce the oxidative stress reacting in three different ways with radical 
species: radical addition, electron transfer or allylic hydrogen abstraction (Fig. 8). 
Figure 8 | Possible carotenoids mechanisms of reaction with radicals [61] 
Epidemiological studies strongly suggest that consumption of carotenoid-rich foods reduces the 
incidence of: i) cancers by the inhibition of tumor cell growth and malignant transformation; ii) 
cardiovascular diseases, preventing the formation of oxidized LDL and as a consequence the 
atherosclerosis onset; iii) eye diseases such as age-related macular degeneration and cataracts;  
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iv) other degenerative diseases such as osteoporosis and neurodegenerative diseases [51, 60, 
61]. 
1.3 Functional foods and Nutraceuticals 
Due to their potential beneficial effects on human health, bioactive compounds could be isolated 
from food sources and used to create functional foods or nutraceuticals. 
The European Commission’s Concerted Action on Functional Food Science in Europe 
(FUFOSE), coordinated by ILSI Europe, reach a consensus on Scientific Concepts of 
Functional Foods, which was published in 1998 [62]. The proposed definition of functional 
food was the following:  
“A food can be regarded as functional if it is satisfactorily demonstrated to affect beneficially 
one or more target functions in the body, beyond adequate nutritional effects, in a way that is 
relevant to either improved stage of health and well-being and/or reduction of risk of disease. 
A functional food must remain food and it must demonstrate its effects in amounts that can 
normally be expected to be consumed in the diet: it is not a pill or a capsule, but part of the 
normal food pattern.”[62] 
As a consequence, functional foods must have the following features: i) being a classical daily 
food; ii) being usually consumed as part of the normal diet, iii) being composed of not synthetic 
components, in concentration normally present in foods or normally supplied by them, iv) 
having a positive effect on specific body functions beyond their nutritive value; v) reducing the 
risk of disease onset, enhancing human health and/or improving life quality (including physical, 
psychologic, and behavioral performances); vi) having validated health claims [62, 63]. 
Practically, functional foods can be: a food naturally rich in bioactive compounds with a 
beneficial effect for human health or a food to which a component was added, removed, 
modified in its structure or bioavailability [63]. Among all these characteristics, a functional 
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food must be safe for human consumption and, as a consequence, its effect on human health 
has to be well-defined starting from the understanding of the mechanisms by which can 
modulate human function as well as the long-term interaction with human body [63]. The 
mechanisms of action can be deeply studied by in vitro experiments and the acute and long-
term interactions with human body by in vivo and clinical studies. In Europe, the functional 
food health claims is regulate by the Nutrition and Health Claim Regulation (NHCR) following 
the Regulation (EC) No 1924/2006 [64] and Regulation (EU) No 2015/2283 [65]. NHCR 
requires substantial scientifically and clinical based results about the effect on human health 
and the safety for human consumption of the considered functional food, to approve its health 
claim. The functional food health claim has to be submitted to the European Commission (EU) 
and subsequently to the European Food Safety Authority (EFSA). EFSA evaluates whether the 
bioactive substances and their interaction with human body were well-characterized and 
whether have a beneficial effect for human health. This regulation was applied also for the 
health claims and safety of food supplements, herbal products, pre- and probiotics, and dietetic 
foods [66], but the term nutraceuticals was not mentioned. 
Nutraceutical was a term coined by Stephen De Felice, as a neologism of the words nutrient 
and pharmaceutical, indicating “food or part of a food that provides medical or health benefits, 
including the prevention and/or treatment of a disease” [67]. Based on this definition 
nutraceuticals were a part of food science that could be defined as “beyond the diet, before the 
drugs” [66]. The above-described European regulation [64, 65] and also EFSA consider 
nutraceuticals as food supplements, so the term nutraceuticals were not officially recognized or 
mentioned, and as a consequence they were not properly regulated [68]. However, while food 
supplements do not have proven pharmacological activity, nutraceuticals, which are composed 
by bioactive substances derived from plant or animal origin, must have pharmacological 
activities more than their nutritional importance [68]. In fact, nutraceuticals are normally used 
to prevent the onset of pathological conditions, such as chronic and degenerative diseases, more 
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than cure them, and to preserve the health status. For this reason, nutraceuticals must be safe, 
effective and with a high bioavailability of the bioactive compounds that have to exert their 
beneficial effect on human health [68]. 
Figure 9 | The use of nutraceutical in the prevention of pathological conditions onset [68] 
 
Different studies showed that nutraceuticals were correlated to the reduction of hypertension, 
hypercholesterolemia, type 2 diabetes, inflammation and oxidative stress associated to the onset 
of chronic and degenerative diseases [68]. At the same time, the consumption of functional 
foods, as a source of bioactive compounds, was correlated with the reduction of the risk 
associated to different pathologies: cancer, cardiovascular diseases and obesity [69]. 
Figure 10 | Potential health benefits of some functional foods [69] 
Nowadays, a large amount of nutraceuticals are available on the market but as above described, 
they are not regulated. Therefore, the available scientific evidences are not enough to support 
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their potential beneficial effect on human health [70]. In the future, nutraceutical research needs 
to be focused on the following nutraceuticals analysis: 
• The determination of an adequate and not toxic recommended dose for human consumption 
• The evaluation of storage and digestion effect on the stability and bioavailability of the 
bioactive compounds 
• The study of bioactive compounds stability, bioavailability, metabolism and the effect of 
the derived metabolites on human tissues 
• The study of possible interactions with cellular macromolecules such as proteins, DNA and 
lipids 
• The determination of possible bioactive compound transformations due to microorganisms’ 
presence in the gastrointestinal tract 
• The evaluation of possible interactions among the different bioactive molecules that 
compose one specific nutraceutical 
• The beneficial effect showed by in vitro and in vivo animal studies must be confirmed by 
clinical trials 
1.4 Intestinal modifications induced in vivo by an excess of nutrients 
Nutrients and food components that were normally ingested with our daily diet were not only 
absorbed but also interact with our intestine. These interactions can strongly modify the 
morpho-functional features of our intestinal cells such as viability, paracellular permeability 
and differentiation as well as proliferation, hormones production, oxidative status and 
immunological response [71]. These modifications can be due not only by the presence of a 
specific nutrient or food component but also by the introduction of an excess of nutrients. In 
fact, in vivo studies showed that obese subjects respond differently to diet nutrients compared 
to lean subjects due to changes in digestion processes and nutrient absorption pathways [72]. 
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This seems to be linked to morpho-functional differences of the intestinal epithelium caused by 
hyperphagia, which is usually the type of diet associated with overweight and obesity [72].  
On the whole, an excess of nutrients can induce the following intestinal adaptations: 
Effect on intestinal epithelial cells proliferation, differentiation and morphology 
An excess of specific nutrients, such as glucose and fatty acids, was able in vivo to increase the 
proliferation rate of the stem cells localized at the base of the intestinal crypts through the β-
catenin pathway [73]. From the stem cells division derived the transit-amplifying cells (TA 
cells), highly proliferating and partially differentiated, that migrate from the crypts to the villi 
originating the differentiated cell types of the small intestine: enterocytes, Goblet cells, Paneth 
cells and enteroendocrine cells (Fig. 11)[74].  
Figure 11 | Distribution of the small intestine cell types. a) Section of an intestinal villus and a crypt. Arrows 
indicate the cells movement from the crypt to the top of the villus. Stem cells are localized at the crypt base together 
with Paneth cells. Above them are localized the transit-amplifying cells (TA cells), which are cells in active 
proliferation derived from stem cells and partially differentiated. Above the TA cells and all along the villus surface 
are localized the other 3 intestinal cell types: Goblet cells, enteroendocrine cells and enterocytes. b) Representation 
of the 4 classes of differentiated intestinal cells derived from stem cells proliferation and differentiation. [74] 
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An excess of nutrients can also induce an unbalanced stem cell differentiation towards the 
enterocytic phenotype instead of Goblet and Paneth cells, while the number of enteroendocrine 
cells remains stable (Fig. 12) [75]. In addition to the augmented number of absorbent 
enterocytes, the excess of nutrients also causes an increase in their mass and protein content 
[76, 77]. Furthermore, the nutrient excess is able in vivo to increase the villi height and the 
crypts depth (Fig. 13) [72, 76, 78]. 
Figure 12 | Variation in the number of the intestinal epithelium cytotypes due to a nutrient excess. A diet 
characterized by an excessive introduction of nutrients leads to an increase in the number of proliferating stem 
cells, TA cells and absorbent enterocytes, as well as a decrease of Paneth and Goblet cells compared to a subject 
that introduces a suitable quantity of nutrients with the diet. Image modified from Mah et al., 2006 [75]. 
Overall, these intestinal modifications result in an increase of the intestinal absorbent surface 
and, consequently, an augmented nutrient absorption capacity of the intestine. 
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Figure 13 | Modifications of the intestinal epithelium morphology due to the introduction of a nutrient 
excess. Subjects that introduce an excessive amount of food with diet, such as obese people, show an increase in 
the intestinal villi height and crypts depth compared to the intestine of lean subjects. Image modified from Dailey 
2014 [72]. 
Effect on the brush border hydrolases activity 
ALP is an enzyme anchored to the enterocyte brush border, which showed a high activity in the 
duodenum followed by a progressive decrease along the small intestine and an increasing 
activity gradient from crypts to villi correlated to the intestinal cell differentiation degree. For 
this reason, ALP has been considered as a sign of enterocytic cell differentiation [79]. Several 
components of the diet, including proteins, fats and carbohydrates, are known to modulate the 
expression or activity of ALP [79]. In particular, the presence of saturated fatty acids cause 
ALP specific activity increase, while unsaturated or polyunsaturated fatty acids induce a 
decrease in the activity of this enzyme [79-82]. Even a diet rich in proteins and amino acids, 
with the exception of L-cysteine and L-tryptophan which are powerful ALP inhibitors, or rich 
in carbohydrates and simple sugars can stimulate ALP activity [79]. In addition to 
macronutrients, other components of the diet, including minerals and vitamins, can also 
influence the activity of this enzyme: free phosphorus has an inhibitory effect while phosphate 
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bonds, Ca2+ and Vitamin K are able to enhance its activity [79, 81]. At the brush border level, 
there are also different peptidases, such as DPP IV and APN, involved in the terminal digestion 
of peptides present in the intestinal lumen after a meal. DPP IV is inhibited by the presence of 
three amino acids (Met, Leu and Trp) and eight dipeptides (Phe-Leu, Trp-Val, His-Leu, Glu-
Lys, Ala-Leu, Val-Ala, Ser-Leu and Gly-Leu) deriving from the digestion of proteins 
introduced with the diet [83]. It is also inhibited by peptides derived from milk protein digestion 
[84]. In literature, there are few studies that investigate whether nutrients can modulate in vivo 
the APN specific activity; the only information available is that a diet rich in proteins leads to 
an APN specific activity increase [85, 86]. 
Effect on intestinal permeability 
Several factors are known to be able to modulate intestinal permeability: bacteria, inflammatory 
cytokines and different components of the diet [87]. The nutrient excess, in in vivo obese 
animals, cause an intestinal permeability increase, that seems to be related to ZO-1 and occludin 
protein decrease which leads to a reorganization of TJ structure [88, 89]. 
Effect on inflammatory cytokines production  
Intestinal epithelial cells are able to produce a wide range of pro-inflammatory cytokines, such 
as IL-8, IL-6 and TNF-α, to communicate with the intestinal immune system. Recent studies 
have shown that the excessive presence of some nutrients at the intestinal level, especially fats, 
is able to induce the production of pro-inflammatory cytokines by intestinal cells causing the 
onset of an inflammatory response [90-92]. Unfortunately, little is known about this nutrient-
induced cytokine release, but this may represent the first inflammatory event that precedes and 
predisposes to the onset of obesity and the characteristic associated low degree of chronic 
inflammation as well as the related diseases [90-92]. 
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Chapter 2  
Development of a new in vitro 
model of human intestinal 
epithelium 
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2.1 AIM 
The first aim of my project was to create an innovative, simpler and more adaptable 
methodology than the previous proposed ones [13, 22-29], to cultivate an intestinal Caco2/HT-
29 co-culture model using the whole parental cell population, suitably differentiated [8, 93] 
before the seeding procedure, instead of subclones or differentiation inducers. The right 
percentage of the two parental cell lines where established with preliminary experiments, which 
were necessary to obtain the correct proportion of absorbent and mucus secreting cells as far as 
possible similar to the intestinal physiological condition. Once found the right percentage, the 
co-culture validity as an in vitro human intestinal model was verified analyzing different 
morpho-functional features such as: i) the presence and localization of absorbent cells, with a 
well-developed apical brush border, mucus secreting cells and the complete paracellular 
junctional apparatus; ii) the activity of enzymes indicative of intestinal cell differentiation 
(Alkaline phosphatase, Dipeptidyl peptidase IV and aminopeptidase N) [94]; iii) the integrity 
of the Tight Junctions and, as a consequence, of the co-culture permeability. Last, the 
percentage and fate of the two cell lines during the post-confluence were studied with a 
fluorescent staining. 
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2.2 MATERIALS AND METHODS 
Unless otherwise specified, all cell culture media and reagents were from Sigma–Aldrich (St. 
Louis, MO, U.S.A.), while FBS was from EuroClone Ltd (West Yorkshire, U.K.). 
2.2.1 Cell Cultures 
The Experimental Zooprophylactic Institute of Brescia provided the two cell lines HT-29 (BS 
TLC 132) and Caco2 (BS TLC 87), from human colon adenocarcinoma, used for all the 
experiments. The two cell lines were separately sub-cultured twice a week, in 75 cm2 flasks 
(VWR International PBI, Milan, Italy), until reaching the right differentiation. In particular, 
HT-29 differentiation towards a polarized cells population with absorptive and mucus secreting 
features [93], was obtained by a sub-cultivation, for at least five-six passages, in Roswell Park 
Memorial Institute medium 1640 (RPMI) supplemented with 10% FBS, 2 mM L-Glutamine, 
0.1 mg/L Streptomycin - 100.000 U/L Penicillin - 0.25 mg/L Amphotericin B and 13.9 mM 
glucose. Whereas the Caco2 differentiation towards the absorptive phenotype was realized sub-
cultivating cells in Eagle’s Minimum Essential Medium (EMEM) supplemented with 15% di 
FBS, 2 mM L-Glutamine, 0.1 mg/L streptomycin -100,000 U/L Penicillin-0,25 mg/L 
Amphotericin-B and 1 mM Sodium Pyruvate, as previously described [8]. In order to create a 
co-culture of these two cell lines, the Caco2 growth medium was changed from EMEM to 
complete RPMI, because it is required to differentiate HT-29 cells, for at least 2 passages before 
the co-culture seeding procedure. The two cell lines were kept at 37 ° C with 5% CO2 and 95% 
atmospheric air and periodically checked to verify the absence of mycoplasma and bacterial 
contamination. Cell growth was constantly monitored using an optical microscope (Nikon 
diaphot phase contrast Elwd 0.3 Japan, power supply model Halogen) and all operations 
requiring sterility were performed under laminar flow hood (Olympia, Celbio).  
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Co-culture of Caco2 and HT-29 cells, as a model of in vitro human small intestinal epithelium, 
was obtained plating different mixtures of differentiated Caco2 (20-40 passages) and HT-29 
(22-40 passages) cells in complete RPMI medium, to obtain the right percentage (30/70, 50/50 
and 70/30 Caco2/HT29). For all the performed experiments, cells were seeded with a density 
of 40.000 cells/cm2 and allowed to growth until 14th day after confluence (T0). Data about the 
co-culture morpho-functional characteristics were obtained, except further specifications, at T0 
and at four different post-confluence days: 3 (T3), 6 (T6), 10 (T10) and 14 (T14); medium was 
changed every 3 days from the seeding procedure. 
2.2.2 Transmission Electron Microscopy (TEM) analysis 
TEM analysis was performed in order to point out cells morphology and ultrastructure. For this 
type of analysis, Caco2 RPMI and 70/30 co-culture were seeded in 10 cm2 petri dishes (Greiner 
Bio-One; Cellstar, Frickenhausen, Germany). At the desired time point, cells were fixed in 2% 
glutaraldehyde in 0.1 M Sorensen phosphate buffer (pH 7.4, 60 min) at room temperature (RT), 
rinsed several times with the same buffer and post-fixed in a solution of 1% osmium tetroxide 
(OsO4) in 0.1 M Soresen phosphate buffer (pH 7.4, 30 min at 4°C). Subsequently, repeated 
washes in sterile distilled H2O at 4° C were carried out followed by enblock staining with an 
aqueous solution of 2% uranyl acetate (15 min, 4°C) and a dehydration in ethanol at increasing 
concentrations (50, 75, 96, 100% ethanol, 5 min each for three times, 4°C). Samples were 
incorporated into Durcupan (Fluka, Milan, Italy), this procedure was accomplished by passages 
in mixtures of absolute ethanol-araldite, containing increasing proportions of resin (15 min for 
each passage, RT), followed by steps in pure araldite (30 min for two times, RT). Resin was 
polymerized for 48 hours at 60°C. Samples were cut in order to obtain transversal semi-cross 
sections with a thickness of about 1.5 μm. The obtained sections were placed on an object slides 
and coloured with methylene blue and observed by an optical microscope. Subsequently, 
ultrathin sections with a thickness of about 80 nm were prepared using an Ultracut 
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ultramicrotome (Reichert Ultracut R-Ultramicrotome; Leika, Wien, Austria) which were placed 
on copper grids. In order to improve the intra- and extracellular contrast, the ultrathin sections 
were stained with uranyl acetate (5% aqueous solution, 45 min, RT) and lead citrate (15 
minutes, RT) than observed by Jeol CX100 electron microscope (Jeol, Tokyo, Japan).  
The length of ten microvilli/selected electron microphotographs was measured and results were 
expressed as mean values ± standard deviation (SD). Statistical significance was set at P<0.01.  
The whole procedure described above and TEM analysis were carried out in collaboration with 
Prof.ssa Elena Donetti, Department of Biomedical Sciences for Health, University of Milan. 
2.2.3 PAS/Alcian Blue staining 
In order to evaluate the mucus production by Caco2 RPMI and 70/30 co-culture, cells were 
seeded in a 24-well plate (BD Falcon Cell Culture Insert PET 1 μm, BD Falcon Companion 
Tissue Culture Plate, Falcon Corning; Life Science, Durham, U.S.A.) and maintained in 
complete RPMI medium. Cells growth on the membrane insert, were fixed in 4% 
paraformaldehyde diluted with 0.1 M Phosphate Buffered Saline (PBS, pH 7.4 for 20 min at 
RT), washed in PBS, and placed in 70% ethanol. Membranes were removed from the inserts 
using forceps. Membranes were wrapped up by folding it four times in lens paper, placed in 
embedding cassettes and incubated in 70% ethanol (3 h on a stirrer). Samples were dehydrated 
through an ascending series of ethanol and paraffin embedding. Membrane sections (4 μm 
thick) were obtained by means of a microtome RM2245 (Leica Microsystems GmbH, Wetzlar, 
Germany), dewaxed and rehydrated through a descending series of ethanol. Sections, after 
rinsing in 3% acetic acid, were stained using 1% Alcian Blue (pH 2.5 for 15 min), oxidized in 
1% periodic acid (5 min), and rinsed in distilled water. Subsequently, sections were immersed 
in Schiff’s reagent (5 min), rinsed in 0.5% sodium metabisulphate (2 min), dehydrated through 
an ascending series of ethanol, and mounted in Entellan. A Nikon Eclipse 80i microscope 
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equipped with a digital camera Nikon DS-5Mc (Nikon, Tokyo, Japan) and an image acquisition 
software (ACT-2U) were used to acquire images of stained cells.  
The whole procedure described above was carried out in collaboration with Prof.ssa Elena 
Donetti, Department of Biomedical Sciences for Health, University of Milan. 
2.2.4 Immunofluorescence analysis of intercellular adhesion  
The presence of a complete junctional apparatus in Caco2 RPMI and 70/30 co-culture was 
evaluated by immunofluorescence. Cells, seeded on glass coverslips, were fixed with 4% 
paraformaldehyde (5 min, RT) in 0.1 mmol/L PBS (pH 7.4), post-fixed in 70% ethanol (4°C), 
and stored at –20°C. The day of the experiment, cells were washed three times with PBS (5 min 
each), incubated with 0.1% Triton X-100 in PBS (15 min, RT), and finally washed several times 
with PBS (RT). Cells intercellular adhesion was evaluated as follows: pre-incubation with 
normal goat serum (1:10) diluted in PBS (30 min, RT) to saturate the non-specific binding sites 
and incubation with primary and secondary antibodies as reported in Tab. 1. Incubation with 
DAPI (1:50000 dilution in bi-distilled water; 5 min, RT) was performed to counterstain nuclei. 
A negative control for each antibody was realized replacing the primary antibody with PBS. 
Table 1 | Protocols of the indirect immunofluorescence [95]  
Primary Antibody Dilution/Incubation time Secondary Antibody
E-cadherin                                   
(36/E-cadherin BD Bioscience)
1:500/1 h RT
Goat anti-mouse                                  
FITC-conjugated                   
(Jackson Immuno research)                               
1:200/1 h RT
Occludin                                   
(Invitrogen)
1:100/overnight 4°C
Goat anti-rabbit                                     
ALEXA FLUOR 488                 
(Molecular Probes)                      
1:100/1 h RT
Desmocollin-2                                  
(Progen)
1:250/1 h RT
Goat anti-rabbit                                     
ALEXA FLUOR 488                 
(Molecular Probes)                      
1:100/1 h RT
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2.2.5 Isolation of cell brush border containing fraction (P2) 
This procedure is necessary to evaluate the specific activity of three brush border enzymes 
indicative of intestinal cell differentiation: Alkaline phosphatases (ALP), Dipeptidyl peptidase-
IV (DPP IV) and Amino Peptidase N (APN). At each time point, Caco2 RPMI and co-cultures, 
previously seeded in 75 cm2 flasks, were detached by means of a cell scraper and collected with 
physiological saline (NaCl 0.9 %, 4°C) in a centrifuge tube. Subsequently, cells were pelleted 
(1300 rpm, 4°C, Eppendorf centrifuge 5810 R USA) and the supernatant was eliminated. Cells 
were subjected to a well-described cell extracts procedure [16, 96]: pellets were re-suspended 
in Tris 2 mM-Mannitol 50 mM buffer (pH 7.1, 4°C) and homogenized by ultra-sonication 
(SONOPLUS Ultraschall-Homogenisatoren, BANDELINE Germany). Each cell homogenate 
(H) was added with CaCl2 (20 mM final concentration) and mixed on a rotating plate (10 min, 
4°C). To obtain the brush border containing fraction (P2), samples were first centrifuged at 950 
× g (4°C for 10 min, Eppendorf centrifuge 5810 R). The formed supernatants were collected 
and centrifuged at 28000 × g (4°C for 30 min, TL-100 Beckman USA). This procedure allows 
obtaining a small pellet consisting in the P2 fraction. This fraction was suspended in 
Tris/Mannitol buffer and used for evaluating the ALP, DPP IV and APN activity. The Lowry 
method was performed on both cell homogenate and P2 fraction to determine the protein 
content [97]. 
2.2.6 ALP Specific Activity Assay 
This method is based on the ALP capacity to convert, by dephosphorylation, the colorless 
substrate p-nitrophenyl-phosphate (PNPP) in the yellow chromogenic p-nitrophenol (PNP). 
The reaction must take place in the presence of Mg2+ ions and alkaline pH to allow the correct 
functionality of this enzyme [98]. ALP activity is proportional to the color intensity produced 
by this reaction. 
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The experimental protocol requires the solubilisation of 20 µL P2 fraction in a final volume of 
550 µL reaction mixture composed by 0.1 M sodium bicarbonate, 5 mM magnesium chloride 
and 7 mM PNPP. The same mixture, devoid of PNPP, was used to prepare two PNP standard 
solutions (10 and 100 nmoles). The reaction took place for 25 min (37°C in the dark) and was 
stopped adding 0.1 M NaOH to each sample. The absorbance was measured at 410 nm by means 
of a spectrophotometer (uniSPEC2 Spectrophotometer, LLG Labware) and the PNP nmoles 
formed during the reaction were obtained using the standard curve. Starting from the PNP 
nmoles produced for each sample, the ALP specific activity was calculated as mU/mg protein 
(one Unit (U) is defined as the enzyme activity able to hydrolyse 1 µmole of substrate in a 
minute). 
2.2.7 DPP IV Specific Activity Assay 
The DPP IV activity assay is based on the reaction between the β-naphthylamine, a colourless 
product released by the hydrolytic action of DPP IV on Gly-Pro β-naphthylamide substrate, and 
the Bratton-Marshall reagent [99]. This reaction leads to a light blue color development. 
DPP IV activity was evaluated as follows: 1 µL of P2 fraction was added in 400 µL of a reaction 
mixture composed by 50 mM Tris-HCl buffer (pH 8.4) and 2 mM Gly-Pro β-naphthylamide. 
At the same time, two standard solutions of β-naphthylamine (3 and 50 µM) were prepared 
using the same buffer devoid of the enzyme substrate. Samples were incubated with the reaction 
mixture for 30 min (37°C in the dark), in order to allow enzyme activity. Trichloroacetic acid 
32% were added to each sample in order to stop the reaction. Since β-naphthylamine is 
colorless, the promotion of color development was done by the addition, in sequence, of 0.3% 
sodium nitrite, 1.5% ammonium sulfamate and 0.1% N-1-naphthyleyhylenediamine 
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dihydrochloride (in 95% ethanol) [100]. The absorbance of each sample was evaluated at 560 
nm and standards were used to calculate the β-naphthylamine µmoles formed by DPP IV 
activity. The enzyme specific activity was expressed as mU/mg protein. 
2.2.8 APN Specific Activity Assay 
The principle of the assay is the L-alanine-p-nitroanilide substrate hydrolysis by APN, which 
leads to the formation of L-alanine and p-nitroaniline (yellow compound) [101]. Color intensity 
is proportional to the activity of the enzyme. 
 
The method consists in the incubation (37°C in the dark) of 10 µL P2 fraction with a solution 
of PBS (30%), CaCl2 (1 mM), MgCl2 (1 mM), 10 mM Tris-150 mM NaCl buffer (1%, pH 8) 
and L-ala p-nitroanilide (1 mM). Two standard solutions of p-nitroaniline (10 and 100 µM) 
were prepared using the same buffer. To stop the reaction, samples were quickly cooled in ice 
for 10 min. The absorbance was evaluated at 405 nm and the formed p-nitroanilide were obtain 
by means of the standard curve. The APN specific activity was expressed as mU/mg protein. 
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2.2.9 Permeability studies 
Transepithelial Electrical Resistance (TEER) 
The formation, development, modulation and integrity of the Tight Junctions (TJ) between cells 
in the different culture conditions was monitored by the Transepithelial Electrical Resistance 
(TEER), evaluated using a Millicell ERS system (Millipore Corporation USA, Fig. 1).  
 
Figure 1 | System for measuring TEER. The longest electrode is placed in the basolateral chamber while the 
shortest electrode in the apical one where the culture grows on a porous filter. [102] 
TEER values represent the measure of the paracellular permeability to ions; increases and 
decreases of the intestinal permeability is associated with the decrease or increase of TEER 
values, respectively. The TEER measurement is normally used to evaluate permeability 
variations of different in vitro cell monolayers, thus allowing monitoring the formation, 
modulation and integrity of the TJ. 
For this experiment, cells were seeded in special 24-well plates (Transwell MillicellR Cell 
Culture Insert PET 1 µm, MillicellR 24-Well Receiver Tray, Millipore Corporation, Billeric, 
MA, USA). Each well consists in an apical chamber, provided at the base of a porous filter (0.7 
cm2 growth area) resting on a basolateral chamber Fig. 2. 
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Figure 2 | Transwell plate and well structures (images modified from https://www.corning.com) 
TEER values were measured, for each condition, in three different regions of the well, then 
averaged, both for cell cultures and in absence of cells (blank). Results were expressed as 
Ω·cm2. 
Lucifer Yellow (LY) 
The co-culture paracellular permeability to large molecules was evaluated using the LY 
fluorescent dye. The experimental protocol consists in seeding cells in 24-well plate (Transwell 
MillicellR Cell Culture Insert PET 1 µm, MillicellR 24-Well Receiver Tray, Millipore 
Corporation, Billeric, MA, USA) and, at the desired time point, cells were washed three times 
with Hank’s Balance Salt Solution (HBSS) to completely remove the growth medium. After 30 
min of cells acclimation in the new buffer, a solution of HBSS containing LY 100 µM was 
added at the apical chamber and incubated for 30, 60 or 120 min. At the end of each incubation 
time, both apical and basolateral solutions were collected, and the LY emitted fluorescence was 
immediately detected (λex = 398 nm and λem = 518 nm) by a luminescence spectrometer (Perkin 
Elmer, Beaconsfield, UK).  
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The apical to basolateral co-culture permeability results were expressed as both the % LYbasal 
recovery and the apparent permeability coefficient (Papp), calculated as follows: 
 
LYt (B) = LY basolateral chamber (B) concentration at a specific incubation time (t = 30, 60, or 120 min);  
LY0 (A) = LY apical chamber (A) concentration at t = 0. 
 
 
S = membrane surface area (0.7 cm2) 
C0 = LY apical chamber (A) concentration at t = 0 
Q = quantity of LY molecules transported in the basolateral chamber in a specific period (t = 30, 60, or 120 min) 
dt = considered incubation time (t = 30, 60, or 120 min) 
 
2.2.10 HT-29 cell staining with PKH26 Fluorescent Dye 
The destiny and the number of HT-29 cells in the 70/30 co-culture, with days in culture, were 
evaluated marking this cell line, before the seeding procedure, with the yellow-orange PKH26 
Fluorescent dye (Cell Linker Kit for General Cell Membrane Labeling) following the kit 
protocol. Briefly, detached HT-29 cells were incubated for 5 min with 20 µM PKH26 and gently 
mixed every 30 sec. Subsequently, cells were washed three times with compete RPMI to 
eliminate the fluorescent excess. This molecule has been chosen because was stably 
incorporated in long aliphatic tails into lipid regions of the cell membrane for a long period and 
during cell proliferation [22]. The stained HT-29 cells were used to create the 70/30 co-culture, 
which was seeded on glass coverslips. At the desired day of post-confluence, cells were fixed 
with 4% paraformaldehyde in 0.1 mmol/L PBS (pH 7.4, 5 min at RT) and washed three times 
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with PBS (5 min each). In order to count cells, DAPI (1:50000 dilution in bi-distilled water; 5 
min of incubation at RT) was used to counterstain nuclei. At the end of the staining procedure, 
for each time point, the total nuclei number of 10 different images, derived from two glass 
coverslips, was counted and the HT-29 percentage was calculated comparing the number of 
labeled cells with the total cells number previously calculated. 
 
2.2.11 Statistical analysis 
Figure 3-5, 10, 11 and Table 4 contain the mean values ± SD from at least three independent 
experiments, each of them composed by almost three replicates. The SPSS 20 statistical 
software (SPSS, Chicago, IL, U.S.A.) was used to reveal whether mean values were statistically 
different either among the different cell culture conditions at the same time point or in the same 
culture at different time points.  The significative differences were evaluated for both cases by 
One-way ANOVA, followed by a Bonferroni post hoc t test, while only in the case of 
comparisons between Caco2 RPMI and 70/30 co-culture at a specific time point, an independent 
two-sample t test was used. The level of significance was considered P<0.05 and was 
represented using different letters for the same type of cells with days in culture or symbols 
among different cell cultures at the same time point. 
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2.3 RESULTS 
2.3.1 Caco2 RPMI and 30/70, 50/50, 70/30 Caco2/HT-29 co-culture features  
The first aim of this project was to identify the right proportion of Caco2 and HT-29 cells to 
create an in vitro model of human small intestinal epithelium with morpho-functional 
characteristics able to mimic as better as possible the in vivo human physiology. In order to 
reach this goal, different proportions of the two cell lines (30/70, 50/50, 70/30 of Caco2/HT-
29) were tested and the main intestinal features were investigated. 
Protein content  
The H and P2 fraction protein content (Fig 3A and B) relative to the 30/70 and 50/50 co-cultures 
remained on the same values at all the analysed time points. In the case of Caco2 RPMI and 
70/30 co-culture, the protein concentration of both H and P2 fraction continuously increased 
until T14. The 70/30 co-culture P2 fraction values were always higher than that reached by 
Caco2 RPMI, but only at T14 there was a statistical significant difference (P<0.01). 
Figure 3 | Protein content determination of homogenate (H) and P2 fraction in Caco2 RPMI and 30/70, 
50/50, 70/30 co-cultures. H (A) and P2 (B) protein concentration was determined at each time point. Statistical 
significative differences (P<0.01) among the different cell cultures mean values, at the same post-confluence day, 
were marked with different symbols (*, # and °). While, mean values assumed by one culture, at different time 
points, were marked with progressive letters when showed a statistical significant difference (P<0.01). [95] 
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Permeability evaluation  
The 30/70 co-culture TEER values ranged from 16 to 38 Ω·cm2 without showing any 
significative variation with days in cultures (Fig. 4). In the case of 50/50 co-culture, TEER 
values significantly increased (P<0.01) until T6, reaching the maximum values of 73 Ω·cm2, 
followed by a decrease to T3 values (60 Ω·cm2). Furthermore, 50/50 co-culture values were 
significantly higher than the 30/70 co-culture ones until T10 (P<0.01). TEER values of the 
70/30 co-culture significantly (P<0.01) rose from T0 to T6 (62-100 Ω·cm2) and afterward 
remained stable from T6 to T14 (100-104 Ω·cm2). The same behaviour was displayed by Caco2 
RPMI TEER values which ranged from 25 to 182 Ω·cm2 and were statistically different from 
the other cultures among all the post-confluence days (Fig. 4).  
Figure 4 | TEER determination of Caco2 RPMI and 30/70, 50/50, 70/30 co-cultures. TEER values were 
determined at each time point. Statistical significative differences (P<0.01) among the different cell cultures mean 
values, at the same post-confluence day, were marked with different symbols (*, #, ° and §). While, mean values 
assumed by one culture, at different time points, were marked with progressive letters when showed a statistical 
significant difference (P<0.01). [95] 
ALP specific activity determination 
ALP activity values of Caco2 RPMI and 30/70, 50/50, 70/30 co-cultures (Fig. 5) increased from 
T0 to T14. Significantly different values were reached only at T10 and T14 for 30/70 and 50/50 
co-cultures (P<0.01), at T10 for 70/30 co-culture (P<0.01) and at T6 and T14 for Caco2 RPMI 
(P<0.05). Caco2 RPMI and 70/30 co-culture absolute values were significantly higher than the 
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30/70 and 50/50 co-cultures values at each post-confluence day. Although the 70/30 co-culture 
ALP absolute values were, at each time point, lower than the Caco2 ones, they showed a 
statistical difference only at T0 (P<0.05). In the case of 30/70 and 50/50 co-culture, the ALP 
specific activity assumed similar values at each post-confluence day.  
Figure 5 | ALP activity of Caco2 RPMI and 30/70, 50/50, 70/30 co-cultures. ALP specific activity values were 
determined at each time point. Statistical significative differences (P<0.01 and P<0.05 only for Caco2 RPMI at 
T6 and T14) among the different cell cultures mean values, at the same post-confluence day, were marked with 
different symbols (*, § and #). While, mean values assumed by one culture, at different time points, were marked 
with progressive letters when showed a statistical significant difference (P<0.01 and P<0.05 for Caco2 RPMI vs 
70/30 co-culture at T0). [95] 
This first part of the study was essential to individuate the right proportion of Caco2/HT-29 cell 
lines for creating the best co-culture model suitable to mimic in vitro the physiology of the 
human intestine. In particular, ALP activity and TEER values (Fig. 4 and 5) that gave 
information, respectively, about intestinal cell differentiation and paracellular permeability, 
allowed the individuation of the 70/30 as the better ratio to develop an in vitro model of human 
intestinal epithelium. In fact, the lower ALP and TEER values of 30/70 and 50/50 co-cultures 
compared to the 70/30 co-culture ones were indicative of poor cell differentiation towards the 
intestinal phonotype and too permeable models.  
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Whereas the 70/30 co-culture values of the same analysed parameters revealed a good degree 
of cell differentiation and a permeability compared to the physiological one (50-100 Ω·cm2) 
[103]. For these reasons, further morpho-functional features of the 70/30 co-culture where 
deeply studied to confirm the validity of this intestinal in vitro model. 
2.3.2 Caco2 RPMI and 70/30 co-culture morpho-functional features analysis  
TEM analysis  
Table 2 | Caco2 RPMI ultrastructure characteristics at different post-confluence days. The presence or the 
absence of a particular cell structure was indicated with + or -, respectively. [95] 
Ultrastructural features of Caco2 RPMI observed by TEM analysis were reported in Tab. 2. At 
T0, this culture formed a continuous monolayer with apical scattered microvilli and few 
paracellular junctions (Fig. 6a and 6b). The same characteristics were present at T3 but with the 
addition of mucus granules production. After sixth days of post-confluence, Caco2 RPMI 
showed increased apical microvilli, paracellular junction presence and started to arrange in a 
multilayer. The same organization was still present at T10, but mucus and microvilli production 
were enhanced than the previous time points. Finally, at T14 (Fig. 6c and 6d), cells formed a 
continuous multilayer which presented an increase in paracellular junction formation and an 
evident decrease in microvilli development. Overall, Caco2 RPMI seemed to be less 
differentiated compared to the Caco2 grown in EMEM [8]. 
 
Time points Cell junctions Microvilli Mucus Cell arrangement
T0 +/- scattered - Continuous monolayer
T3 - scattered + Continuous monolayer
T6 + + +
Continuous monolayer 
with multilayer
T10 +/- ++ ++
Continuous monolayer 
with multilayer
T14 ++ +/- ++ Multilayer
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Figure 6 | TEM images of Caco2 RPMI. Representative microphotographs of Caco2 RPMI at T0 (a, b) and at 
T14 (c, d). Bars: 2 µm (a, c) and 500 nm (b, d); Desmosomes and TJ were indicated respectively by arrows and 
asterisks. [95] 
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Table 3 | 70/30 co-culture ultrastructure characteristics at different post-confluence days. The presence or 
the absence of a particular cell structure was indicated with + or -, respectively. [95] 
The original and interesting ultrastructure features of 70/30 co-culture, observed by TEM 
analysis, were reported in Tab. 3. When cells reached the confluence (T0), it is evident a 
reduced differentiation degree highlighted by the poorly presence of paracellular junctions and 
microvilli (Fig. 7a and 7b). At T6, the 70/30 co-culture was just arranged in a multilayer with 
Follicle-Like Structures (FLS), these structures were formed by intracellular spaces, at the cell 
lateral membrane level, which showed the presence of small microvilli (Fig. 7c). Furthermore, 
cells of the multilayer upper side were characterized by the presence of mucus granules, a well-
developed brush border (Fig. 7c and 7d) and a complete junctional apparatus (Fig. 7d and 7e). 
After fourteen days of post-confluence, the 70/30 co-culture showed an increment of 
paracellular junction (especially desmosomes, Fig. 7h) and microvilli presence (Fig. 7f and 7g), 
which were also more regular and elongated than T6 (0.5 ± 0.12 µm at T6 vs 1.88 ± 0.34 µm at 
T14, P<0.01). On the contrary, mucus production seemed to be disappeared.  
 
 
Time points Cell junctions Microvilli Mucus Cell arrangement
T0 +/- +/- +/- Continuous monolayer
T6 + + + Multilayer
T14 ++ ++ - Multilayer
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Figure 7 | TEM images of 70/30 co-culture. Representative microphotographs of 70/30 co-culture at different 
time points: T0 (a, b); T6 (c-e); T14 (f-h). Bars: 2 µm (a, c, g); 1 µm (f) and 500 nm (b, d, e, h); Desmosomes, TJ 
and FLS were indicated respectively by arrows, asterisks and arrowheads. [95] 
Mucus secreting cells staining  
In the PAS/Alcian Blue staining of Caco2 and 70/30 co-culture (Fig. 8), the mucus secreting 
cells were evidenced by a reddish-violet staining while the non-mucus secreting cells were 
indicated by a bluish cytoplasmic background. The Caco2 RPMI culture showed, in accordance 
with TEM analysis (Tab. 2), an evident and prevalent mucus secreting cytotype at T14 (Fig. 
8a), while the 70/30 co-culture showed a similar staining already at T6 (Fig. 8b) that at T14 
disappeared (Fig. 8c), thus indicating the prevalence of non-mucus secreting cells as revealed 
by TEM analysis (Tab. 3). 
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Figure 8 | PAS/Alcian Blue staining of Caco2 RPMI and 70/30 co-culture. Representative photomicrographs 
of Caco2 RPMI at T14 (a) and 70/30 co-culture at T6 (b) and T14 (c). Bars: 10 µm (a, b, c). Stained cells were 
indicated with arrows, while arrowheads marked unstained cells. [95] 
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Immunofluorescence analysis 
The positive immunoreactivity always localized at the membrane level of Caco2 RPMI and 
70/30 co-culture, at T6, revealed the presence of occludin (Fig. 9a and 9b), E-Cadherin (Fig. 9c 
and 9d) and Desmocollin-2 (Dsc-2, Fig. 9e and 9f) transmembrane proteins and, accordingly, 
of the TJ, adherent junctions and desmosomes. 
Figure 9 | Immunofluorescence analysis of Caco2 RPMI and 70/30 co-culture. Representative 
photomicrographs, at T6, of the Caco2 RPMI (a, c, e) and 70/30 co-culture (b, d, f) immunostaining of the 
intracellular adhesion markers: occludin (a, b); E-Cadherin (c, d); Dsc-2 (e, f). Bars: 10 µm. [95] 
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APN and DPP IV specific activity 
Figure 10 | APN and DPP IV Activity of Caco2 RPMI and 70/30 co-culture. APN (A) and DPP IV (B) specific 
activity values were determined at each time point. Statistical significative differences among the two cell cultures 
mean values, at the same post-confluence day, were marked with *. Mean values assumed by one culture, at 
different time points, were marked with progressive letters when showed a statistical significant difference. A 
P<0.05 was considered significant. [95] 
The Caco2 RPMI APN activity values started to significantly (P<0.05) increase at T6, reaching 
the maximum value at T10 (P<0.01), while the 70/30 co-culture absolute values remained 
almost stable until T10 followed by a significative rise at T14 (P<0.01, Fig. 10A). In the case 
of DPP IV (Fig. 10B), a significative increase (P<0.01) of activity was observed from T0 to 
T10, for Caco2 RPMI, and from T0 to T14, for 70/30 co-culture. The 70/30 co-culture absolute 
values were significantly lower than Caco2 RPMI: at each time point in the case of APN activity 
(P<0.01) and only at T0, T6 and T10 for DPP IV activity (P<0.01 at T0 and P<0.05 at T6 and 
T10). 
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LY permeability evaluation 
Considering mucus production and the presence of a complete paracellular junctional 
apparatus, the 70/30 co-culture at T6 seemed to be the best in vitro model of small intestine. 
Since these characteristics were fundamental but not enough to confirm this theory, the 
paracellular permeability features to large molecules, which are a key factor for nutrient and 
drug absorption, were investigated using LY.  
The LY concentration in the basolateral chamber of Caco2 RPMI remained constant at each 
incubation times, while in the 70/30 co-culture the % of LYbasal recovery significantly increase 
starting from 60 min (t60) of incubation (P<0.01, Fig. 11A). In the case of Papp evaluation (Fig. 
11B), both Caco2 RPMI and 70/30 co-culture values did not differ from t0 to t120 and assumed, 
respectively, the following range of values 0.2-0.7·10-6 cm/sec and 1.4-2.7·10-6 cm/sec. The % 
of LYbasal recovery and Papp of 70/30 co-culture were significantly higher than Caco2 RPMI 
(P<0.01 and P<0.05, respectively) at t60 and t120 and were comparable to the in vivo human 
intestinal epithelium. 
Figure 11 | LY permeability evaluation of Caco2 RPMI and 70/30 co-culture at different incubation times 
(0, 30, 60 and 120 min). % LYbasal recovery (A) and Papp (B) values were determined at T6. Statistical significative 
differences among the two cell cultures mean values, at the same incubation times, were marked with * and #. 
Mean values assumed by one culture, at different incubation times, were marked with progressive letters when 
showed a statistical significant difference. P<0.05 was considered significant. [95] 
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Determination of HT-29 cell fate and content with days in culture 
Figure 12 | HT-29 cell staining with PKH26 red fluorescent dye in the 70/30 co-culture at different post-
confluence days. HT-29 were marked in red fluorescence while nuclei were marked in blue fluorescence (DAPI). 
Staining were evaluated at T0 (a), T3 (b), T6 (c), T10 (d) and T14 (e); white arrow indicates domes formed by 
HT-29 cells (f). Bars: 100 µm. [95] 
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The percentage of HT-29 cells in the 70/30 co-culture were evaluated using the images acquired 
after HT-29 cells staining with the red fluorescent PKH26 from T0 to T14 (Tab. 4 and Fig. 12). 
At T0, the calculated percentage of 59.3 ± 4.5 for HT-29 indicated a higher presence of this cell 
type in the co-culture than Caco2. Starting from T3 the % of HT-29 (30.4 ± 4.8) significantly 
decreased compared with T0 (P<0.01) until reaching the lowest value at T14 (18.4 ± 6.4 %). 
At this time point, the presence of domes formed by HT-29 cells were evident. 
Table 4 | HT-29 and Caco2 percentage in the 70/30 co-culture with days in culture. Table shows mean values 
± SD calculated as reported in paragraph 2.2.10 of Materials and methods section. Asterisk (*) indicated any 
significant difference respect to T0 (P<0.01). [95] 
 
 
 
 
 
 
 
 
 
Time points % HT-29 % Caco2
T0 59.3 ± 4.5 40.7 ± 4.5
T3 30.4 ± 4.8* 69.6 ± 4.8*
T6 22.2 ± 5.2* 77.8 ± 5.2*
T10 27.1 ± 10.2* 72.9 ± 10.2*
T14 18.4 ± 6.4* 81.6 ± 6.4*
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2.4 DISCUSSION 
The setup of the 70/30 co-culture model derived from the necessity to tune a standardized, 
simple, time saving and useful methodology for cultivating an in vitro model of human 
intestinal epithelium, with morpho-functional features comparable to the in vivo human 
physiological ones, without using HT-29 subclones, particular growth conditions/supports or 
3D cultures [13, 23, 25, 27, 29]. The use of a Caco2/HT-29 co-culture allowed overcoming the 
limits of the in vitro models formed only by parental Caco2 and HT-29 or Caco2/HT-29 
subclones co-cultures, reaching the percentage of enterocyte and mucus secreting cells 
comparable to the human small intestinal epithelium (90% and 10%, respectively) [104]. In 
addition, the use of the entire HT-29 cell population allowed obtaining a mixed population 
fundamental to reach the right proportion of the two different intestinal cell phenotypes [20, 
94]. Last, the contemporary presence of Caco2 and HT-29 permitted to reach realistic 
permeability values: monolayers formed only by Caco2 cells showed too lower permeability 
values than the in vivo ones [12], on the contrary, HT-29 irregular monolayers are too permeable 
[20, 22, 23]. To understand which was the most suitable Caco2/HT-29 cells ratio to obtain an 
in vitro model able to mimic at best the in vivo human intestinal features, three different co-
cultures (30/70, 50/50 and 70/30 Caco2/HT-29) were preliminary cultured and analysed for the 
following features: H and P2 fraction protein content, ALP activity and TEER values. Values 
obtained were compared with the Caco2 RPMI culture. From these preliminary studies, the 
70/30 co-culture turned out to be the ratio with the best characteristics compared with the other 
two co-cultures, in fact showed the highest P2 fraction protein content at T14, which was 
confirmed by the increased presence of microvilli revealed by TEM analysis. At the same time, 
the ALP activity values were always significantly higher than the 30/70 and 50/50 ratios, thus 
indicating a greater intestinal cell differentiation degree. In addition, TEER values confirmed 
the 70/30 co-culture as the best ratio because assumed a range of values comparable to the in 
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vivo ones (50-100 Ω·cm2) [103]. The 70/30 co-culture was investigated more in detail for 
further morpho-functional features indispensable to validate this in vitro intestinal model. The 
morphological analysis revealed two time points with interesting characteristics: T6 and T14. 
At T6 there was a contemporary presence of absorbent cells, with a well-developed brush 
border, and mucus secreting cells, fundamental to create the mucus barrier needed to protect 
the intestinal epithelium from exogenous molecules/pathogens and to regulate nutrient 
absorption [105, 106]. TEM and immunofluorescence analysis revealed a complete junctional 
apparatus at the lateral membrane level and the good status of the TJ was confirmed by TEER 
and LY permeability studies, which revealed TEER and LY Papp values comparable to the 
human intestinal ones [103]. Considering this time point, the 70/30 co-culture permitted to 
obtain an in vitro well-differentiated intestinal model in fewer days compared to the previous 
published methodologies. This goal was reached combining the use of: i) Caco2 with a passage 
number higher than 20 [8] together with post-confluence [5]; ii) the total heterogeneous parental 
population of HT-29 cells; iii) RPMI medium, which led to the HT-29 differentiation in both 
absorptive and mucus-secreting cells. The cultivation of Caco2 in RPMI seemed to reduce the 
differentiation pathway of this cell line when compared to Caco2 grown in EMEM [8]. The 
second important time point was T14, in this case the absence of mucus production, confirmed 
by PAS/Alcian Blue staining, and the presence of enterocytes with a higher number of 
microvilli than T6, as revealed by TEM, were indicative of a well-differentiated but only 
absorptive epithelium. These characteristics raised the question of the HT-29 cell fate in the co-
culture: the HT-29 cell staining, with the red fluorescent dye, revealed that the percentage of 
this cell line decreased with days in culture reaching the lowest value of 18.4% at T14. At this 
time point, in correspondence of HT-29 cells, appeared specialized cell structures named 
domes, which were charged to transepithelial nutrient transport [94]. Based on this observation, 
probably HT-29 cells changed their phenotype towards the absorptive one with days in culture. 
Another important 70/30 co-culture feature present at these two time points was the multilayer 
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cell organization; this observation was in agreement with different articles reporting cell 
differentiation methods [5, 13, 28]. At T6 and T14, the 70/30 co-culture displayed the formation 
of FLS that were described as intra- or intercellular structures characterized by the capacity to 
exert absorption or secretion functions together the possible presence of functional microvilli 
[107]. These structures normally were formed spontaneously at the lateral membrane level of 
polarized cells with a complete paracellular junctional apparatus and for this reason could be 
consider as another index of cell differentiation [107]. In addition to all the above-described 
features showed by the 70/30 co-culture model, it is important to emphasize also the morpho-
functional correlations that this co-culture displayed during the different post-confluence days. 
First, the activity of the brush border associated enzymes (ALP, DPP IV and APN) continuously 
increased from T0 to T14, reaching the maximum value at this last time point. This rise was 
correlated with the augmented presence of microvilli showed at T14 compared with T6 and at 
T6 compared with T0. This correlation, associated with the mucus disappearance at T14, again 
strongly suggested the progressive change of cell phenotype towards the exclusive absorptive 
one. Second, the continuous maturation and modification, with days in culture, of the 
paracellular junctional apparatus was associated: i) at T6, with the highest TEER value, index 
for abundant and functional TJ; ii) at T14, with a TEER value lower than T6, which was 
correlated with the increased presence of desmosomes that do not contribute to the paracellular 
permeability as TJ. The interaction between the two cell lines during all the post-confluence 
period brought to a change in cell phenotype, morphology and functionality underlining the 
versatility and again the suitability of the 70/30 co-culture as an in vitro model of human 
intestinal epithelium.  
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Chapter 3 
Applications of the 70/30 
Caco2/HT29 co-culture for studying 
nutrients digestion and absorption 
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3.1 AIM 
The need to evaluate the effect of nutraceuticals and functional foods on human body have to 
start from studying the bioactive compounds mechanisms of action. As previous described (see 
Chapter 1), the first approach was to use cellular in vitro models.  
Therefore, the aim of this part of the project was to study the interaction between intestine and 
bioactive compounds released from nutraceuticals and functional foods after digestion, creating 
an experimental setup as far as possible comparable to what happens in the human 
gastrointestinal tract after food ingestion. First, to mimic human digestion, food samples were 
subjected to an in vitro simulated gastrointestinal digestion [108]. Once digested, samples were 
administered to the 70/30 Caco2/HT-29 co-culture (see Chapter 2), as in vitro human intestinal 
model [95], both at physiological dose, calculated starting from the daily recommended dose 
of the starting food, as defined by LARN (2014) [109], in relation to the total surface area of 
intestinal absorption, and in excess. Two different studies were performed to demonstrate the 
suitability of the co-culture model to study absorption and nutrient/food-intestine interactions 
at molecular and biochemical level: 
• In the first work, the bioactivity of carotenoids, tocols, phenolic acids and polyphenols 
released after in vitro digestion of five different experimental water biscuits (WB), prepared 
with a mixture of bread wheat, einkorn and pseudocereals, was evaluated. In particular, the 
possible cytotoxicity and antioxidant activity of WB digestates on the intestinal epithelium 
was studied using the co-culture model. 
• In the second work, the effect of Lactic Acid Bacteria (LAB) or Saccharomyces cerevisiae 
(SC) leavening activities on the bioactive features of five different experimental breads was 
evaluated. The obtained bread samples were subjected to in vitro gastrointestinal digestion 
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and administrated to the co-culture model to evaluate the possible effect on intestinal cell 
viability, paracellular permeability and anorectic hormone production. 
3.2 MATERIAL AND METHODS 
3.2.1 Samples preparation and characterization 
Water Biscuits  
Five WBs were prepared mixing different type of wholemeal flours: 
• 100% bread wheat 
• 70% einkorn and 30% buckwheat 
• 70% einkorn and 30% amaranth 
• 70% einkorn and 30% quinoa 
•  100% einkorn 
Einkorn (Triticum monococcum L. ssp. monococcum cv. Monlis), common wheat for biscuits 
(Triticum aestivum L. ssp. aestivum cv. Bramante), amaranth (Amaranthus cruentus L. cv. MT-
3), and buckwheat (Fagopyrum esculentum Moench local population Seis) seeds were produced 
in 2014 in the fields of the Consiglio per la ricerca in agricoltura e l’analisi dell’economia 
agraria (CREA) – Research Unit for the Selection of Cereals (Sant'Angelo Lodigiano, LO, 
Italy). Seeds were stored at 5°C, after harvesting. Quinoa (Chenopodium quinoa Willd) sample 
came from the market. Wholemeal flour of all samples was prepared using a Cyclotec 1093 lab 
mill (FOSS Tecator, Denmark). 
Each WB was prepared blending, for 90 sec using a Hobart C-100 electric mixer (National 
MFG CO, USA), 80 g of wholemeal flours alone or in different mixture, at 14 % humidity, and 
35 mL of deionized water. The obtained doughs were rolled at 7 mm height, cut with a die 
cutter, to obtain an identical shape for each WB, and backed at 205 °C for 30 min, in an ovenlab 
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rotatory oven (National MFG CO, U.S.A.). The prepared WBs were cooled at RT for 30 min 
and stored at -20 °C. 
WBs were prepared by Prof.ssa Alyssa Hidalgo from Department of Food, Nutrition and 
Environment Sciences (DeFENS), University of Milan, Italy. 
Breads 
The five bread fermented doughs were prepared using SC or four different LAB strains: 
Lactobacillus reuteri (LR12) and Lactobacillus fermentum (LF16) provided by Centro 
Sperimentale del Latte (Zelo Buon Persico, Italy), Lactobacillus parabuchneri (BT117) and 
Leuconostoc lactis (BT124) from the bacterial collection of the Institute of Sciences of Food 
Production – Italian National Research Council (Milan, Italy). SC or LABs were first inoculated 
(1010 CFU) in 125 g of commercial wheat flour mixed with 75 mL tap water, containing 2 g 
NaCl, in a KitchenAid® mixing bowl (model 5KSM150, KitchenAid, Benton Harbor, MI, USA) 
equipped with a dough hook, fixing the mixing speed at level 2 for 2 min. Afterword,  2.5 mL 
of virgin olive oil was added and the sourdoughs were mixed again for other 4 min. The 
sourdoughs fermentation occurred at 22°C for 15 h. The final bread doughs were prepared 
mixing, for 6 min, 140 g of each fermented sourdough, from SC or LABs inoculum, 700 g of 
commercial wheat flour, 420 mL tap water, 14 g of virgin olive oil and 10.5 g NaCl. The final 
prepared doughs were rested for 10 min at RT, then divided into portions of 250 g each, shaped 
into cylinder form and put into a baking pan (8 cm height). The last proofing was carried out at 
37°C and 60% humidity for 5 h and doughs were baked in an oven (Rational AG, Mestre, Italy) 
at 220 °C for 30 min.  
Before baking, each dough was analysed to evaluate the pH reached at the end of the 
fermentation process and the Total Titratable Acidity (TTA) due to the presence of acids, such 
as lactic and acetic acid. Analysis were performed by means of a T50 automatic titrator 
(Mettler-Toledi AG, Greifensee, Switzerland). Briefly, 20 g of each dough was suspended in 
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200 mL of distilled water and titrate by adding a solution of NaOH 0.1 M until reaching the pH 
8.4. TTA results were expressed as mL NaOH/10 g of sample. 
The leavening capacity of LABs were compared with those of SC looking at the sponge dough 
obtained using the same leavening and preparation procedure. The bread loaf apparent volume 
(mL/g) was determined as follows: first, bread weight was measured with an electronic balance 
Europe 1700 (Gibertini Elettronica Srl, Novate Milanese, Italy) and the specific volume was 
determined through the volume/mass ratio [110]. Furthermore, the breads moisture content was 
evaluated drying the sample at 130°C, until its weight remained constant for 60 s, and using an 
infrared balance (MA 210.R, Radwag-Wagi Elektroniczne, Chorzòw, Poland). 
Finally, the phytate degradation activity due to SC and LABs fermentation was evaluated using 
the phytic acid (phytate)/total phosphorus K-PHYT 05/17 kit (Megazyme, Bray, Ireland), 
following kit protocol.  
Bread doughs preparation and characterization were performed in collaboration with Prof. 
Ivano De Noni, Department of Food, Nutrition and Environment Sciences (DeFENS), 
University of Milan; and Milena Brasca Institute of Sciences of Food Production (ISPA), 
National Research Council (CNR). 
3.2.2 WBs and Breads in vitro digestion and digestates characterization 
In vitro static gastrointestinal digestion 
WB and Bread samples were subjected to the static in vitro gastrointestinal digestion protocol 
proposed by Minekus et al. [108]. Briefly, 2.5 g of WBs or breads were smashed for 2 min with 
2.5 mL of Simulated Salivary Fluid (SSF, pH 7), containing salivary α-amylase (75 U/mL), in 
a mincer to reproduce mastication. The obtained oral bolus (5 mL) was mixed with 5 mL of 
Simulated Gastric Fluid (SGF, pH 3) added with porcine pepsin (2000 U/mL). The gastric 
digestion was carried out at 37°C for 2 h maintaining pH 3. Gastric bolus (10 mL) were added 
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with 10 mL of Simulated Intestinal Fluid (SIF, pH 7) containing pancreatic enzymes (porcine 
trypsin 200 U/mL, bovine chymotrypsin 50 U/mL, pancreatic amylase 200 U/mL, porcine 
intestinal lipase 4000 U/mL and co-lipase, mass ratio colipase:lipase = 1:2) and bile acids (10 
mM). Intestinal digestion was performed at 37°C for 2 h maintaining pH 7. Enzymatic reactions 
were stopped adding 4-(2-Aminoethyl) benzenesulfonyl fluoride (1 mM in the final solution), 
a proteases inhibitor, and immediately frozen at -80° C. Digestates were also subjected to a 
centrifugation (4000 g, 20 min at 4°C) in order to separate the insoluble (sediments) and soluble 
(supernatant) fractions, this last fraction was used to perform the cellular experiments. 
Following the same digestion protocol, a blank of digestion (BD) containing only enzymes 
without samples was obtained and used to evaluate the interference due to the presence of 
digestive enzymes and buffers. 
The in vitro static digestion of WB and bread samples was performed in collaboration with 
Prof. Ivano De Noni, DeFENS, University of Milan. 
Digestates characterization  
WB digestates 
Before using WB digestates for cellular experiments, the carotenoids, tocols, phenolic acids 
and total polyphenols (TPP) content was evaluated both in the supernatant and in the sediment 
of each digestate. Briefly, carotenoids and tocols were extracted and quantified by NP-HPLC 
as described by Hidalgo et al. (2010) and Hidalgo and Brandolini (2010), respectively [111, 
112]. Total carotenoids were computed as the sum of the different compounds (α- and β-
carotene, β-cryptoxanthin, zeaxantin and lutein), while total tocols was the sum of tocopherols 
and tocotrienols. The soluble conjugated and insoluble bound phenolic fractions presence was 
evaluated by a solvent extraction [113] and quantified by NP-HPLC as described by Brandolini 
et al. (2013) [114]. The total amount of phenolic acids was the sum of conjugated and bound 
fractions. Carotenoids, tocols and phenolic acids content of samples were expressed as mg/kg 
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of dry matter (DM), obtained by oven-drying samples at 130°C for 6 h. The TPP were extracted 
as described by Yilmaz et al. (2015) [113] and quantified using the Folin-Ciocalteu reagent. 
TPP results were expressed as mg ferulic acid equivalent (FAE)/kg DM. WB digestates were 
also tested for their in vitro antioxidant activity in test tubes using the FRAP method [113, 115], 
these results, expressed as mmol of Trolox equivalent (TE)/kg DM, were compared with the 
ones obtained from the cell-based antioxidant activity assay. All the results obtained from WB 
digestates were compared to the values found for the same analysis carried out on undigested 
WBs. 
These preliminary experiments were performed in collaboration with Prof.ssa Alyssa Hidalgo, 
DeFENS, University of Milan. 
Breads digestates 
In the case of bread samples, preliminary experiments were performed to evaluate the starch 
hydrolysis before and after in vitro gastrointestinal digestion. Briefly, the content of maltotriose, 
maltose and glucose were evaluated by HPLC following the protocol reported by Resmini et 
al. 1993 [116]. Furthermore, the rapidly (RDS) and slowly (SDS) digestible starch as well as 
the total amount and the resistant fraction were calculated after 20 and 120 min of in vitro starch 
hydrolysis thanks to the released glucose evaluated by HPLC [117].  
These experiments were performed in collaboration with all my co-authors. 
3.2.3 Use of the intestinal co-culture 
For all the cellular experiments, the in vitro intestinal cell model formed by 70/30 Caco2/HT-
29 co-culture [95], deeply described and characterized in Chapter 2, was used at the sixth day 
of post-confluence, except when further specified.  
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3.2.4 Dose selection for experiments with co-culture cells 
The osmolarity of each digestates was checked and corrected at the physiological value of 300 
mOsm/Kg H2O (Osmometer basic, Lӧser, Messtechnik, Germany) to avoid cell osmotic shock. 
WB and bread digestates were administered to cells at the physiological dose calculated on the 
base of WB and bread 50 g serving size for adults according to the LARN 2014 [109]. After 
ingestion, this portion will be distributed on 200 m2 of the intestinal surface area thus 
corresponding to the physiological dose of 25 µg/cm2 of digested WB or bread. Based on this 
dose and considering the volume reached by each digestate after the osmolarity correction, the 
following digestates volumes were administered for cm2 of growth cell area: 0.29 µL/cm2 for 
SC, 0.3 µL/cm2 for BT124 and BT117, 0.31 µL/cm2 for LF16 and LR12, 0.35 µL/cm2 for each 
WB. In the case of WBs, in addition to the physiological dose (named 1x) digestates were tested 
ten (10x), fifty (50x) and one hundred (100x) times higher to compare the preliminary FRAP 
values obtained using the 100x dose. Furthermore, the possible effects of BD on cells was 
evaluated administering the same volume of enzymatic buffer present in the tested dose.   
3.2.5 Cell viability assay (MTT and Trypan Blue) 
Co-culture cell viability, after digestates administration, was evaluated using the MTT (3-(4,5-
Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide) assay [118]. Briefly, co-culture 
cells were seeded in 24-well plates at 40.000 cells/cm2 in 1 mL of complete RPMI and allowed 
to growth until reaching 80% of confluence. The day of the experiment, medium was replaced 
with 1 mL of RPMI containing WB and bread digestates at the right dose. After two hours of 
cell incubation with digestates, samples were discharged, replaced with 510 µL of a solution 
composed by 500 µL RPMI and 10 µL MTT (5 mg/mL) and incubated for 4 h. This assay 
evaluates the mitochondrial dehydrogenases ability to cut the MTT (yellow) tetrazole ring with 
subsequent formation of formazan salts, visible thanks to the formation of blue/purple crystals 
in viable cells. At the end of the incubation period, formazan salts were solubilized using 500 
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µL of DMSO (Dimethyl Sulfoxide). The amount of formazan salts produced is directly 
proportional to the living cells number and was measured by a spectrophotometer (Wallac 
Victor2 1420 Multilabel Counter, Perkin Elmer) at a wavelength of 570 nm. Results were 
expressed as % vs CTRL (not treated cells) and were the mean value ± SD of three independent 
experiments each consisting in 3 replicates. 
In the case of 50x and 100x WB digestates administration, the Trypan blue assay [119] was 
performed in order to assess the viability of detached cells.  
3.2.6 TEER evaluation 
The effect on co-culture paracellular permeability, after incubation with bread digestates at the 
considered doses, was evaluate in co-culture at T6, when it displays TEER and LY Papp values 
comparable to the human small intestine [95]. Co-culture was seeded in 24-well plates 
(Transwell MillicellR Cell Culture Insert PET 1 µm, MillicellR 24-Well Receiver Tray, 
Millipore Corporation, Billeric, MA, USA), each well contained 400 µL and 800 µL of RPMI 
in the apical and basolateral chamber, respectively. At T6, a solution of 400 µL RPMI 
containing digestates at the right dose was administered in the apical chamber of each well, 
while in the basolateral one medium was replace with 800 µL of fresh RPMI. TEER was 
measured after 2 h incubation (t120). Results were expressed as % vs CTRL (not treated cells) 
and were the mean value ± SD of three independent experiments each consisting in three 
replicates. 
3.2.7 Cell-based antioxidant activity assay (CAA assay) 
The CAA assay was performed according to a well-established protocol [120, 121] with minor 
modifications. Cells were seeded in 96 black well plates (Grainer bio-one CELLSTAR°, Italy) 
and allowed to growth until T6. At this time point, medium was removed and cells were washed 
with 100 µL of PBS. Afterwards, cells were incubated (at 37°C for 20 min) with 100 µL of a 
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HBSS solution containing 10 mM Hepes and 60 µM of the fluorescent probe 2’-7’-di-
chloroflourescin diacetate (DCFH-DA). Subsequently, cells were incubated with 100 µL of 
HBSS (10 mM Hepes) containing WB digestates alone or in presence of 500 µM 2,2’-azobis(2-
methylpropionamide) dihydro-chloride (AAPH), which is an oxidant able to spontaneously 
generate ROS. Each plate included: CTRL cells (not treated) to evaluate the basal oxidative 
status of the co-culture; cells incubated only with 500 µM AAPH (oxidative control) and cells 
incubated with 750 µM of L-Glutathione (GLUT, antioxidant control). Fluorescence (λex=485 
and λem=538) was measured immediately after samples addiction (t0) and every 10 min for 2 h 
(t120).  
Figure 1 | CAA assay principle. Cells were treated with non-fluorescent DCFH-DA that diffuse through the 
membrane and its diacetate residue was removed by cellular esterase. The produced non-fluorescent DCFH 
remains entrapped into the cell cytoplasm. AAPH spontaneously produces ROS both in the extracellular and 
intracellular milieu; ROS in turn oxidize the non-fluorescent DCFH into the fluorescent molecule DCF. 
Antioxidants (AOx) prevent the oxidation of DCF and therefore the emitted fluorescence. [121] 
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Values obtained were analysed to calculate the CAA unit as follows:  
 
ʃSA = the integrate area under the time curve of sample 
ʃCA= the integrate area under the time curve of CTRL 
Positive values of CAA units were indicative of antioxidant activity compared to CTRL (CAA 
unit = 0) while negative values corresponded to oxidative activity vs CTRL. Results were 
expressed as the CAA unit mean value ± SD of three independent experiments each consisting 
in three replicates. 
3.2.8 Peptide YY (PYY) co-culture production 
Co-culture at the sixth day of post-confluence, previously seeded in 6-well plates (Grainer bio-
one CELLSTAR°, Italy), were incubated with 2 mL of RPMI containing bread digestates for 
24 h. At the end of the incubation period, medium was collected in separate eppendorf, 
centrifuged to remove any cells presence in suspension and conserved at -80°C. Medium was 
used to measure the PYY production, after samples incubation, by co-culture cells using an 
ELISA kit. The ELISA assay was performed by LABOSPACE s.r.l. (Milan, Italy).  
3.2.9 Statistical analysis 
Results were expressed as the mean value ± SD from at least three independent experiments, 
each of them composed by almost three replicates. Statistical significant differences between 
mean values were evaluated by One-way ANOVA followed by: i) a Bonferroni post hoc t test 
using the SPSS 20 statistical software (SPSS, Chicago, IL, U.S.A.) for the cell-based 
experiments; ii) a Fisher’s LSD test using the STATGRAPHICS Centurion (Statpoint 
Technologies, Inc., VA, USA) for the tocols, carotenoids, phenolic acids and polyphenols 
63 
 
evaluation; iii) a Tuckey HSD test using MiniTab Software (Minitab Ltd, Coventry, UK) for 
breads samples physical and chemical determinations. A P<0.05 was considered significant.  
3.3 RESULTS 
3.3.1 WB samples features 
Carotenoids, tocols, phenolic acids and TPP content of WBs and their digestates  
The WB composed only by einkorn flour showed the highest carotenoid and tocol content, 
while the bread wheat WB contained the lowest quantity of these two compounds. These 
observations were valid both for undigested WBs and their digestate supernatants (Tab. 1). The 
WB enriched with buckwheat was the richest in TPP, followed by amaranth and quinoa, while 
bread wheat resulted the poorest WB in TPP (Tab. 1). After gastrointestinal digestion the 
soluble TPP concentration in WB digestate supernatants increased for each sample but, in this 
case, the addition of pseudocereals flour did not increase the TPP content compared to the 
einkorn WB (Tab. 1). 
Table 1 | WB and their digestates content of total carotenoids, tocols and TPP. Significant statistical 
differences between WB samples were marked with different letters for each compound. Results were expressed 
as mg/kg DM for carotenoids and tocols and as mg FAE/kg DM for TPP. P<0.05 was considered significant. [122] 
Sample Water biscuit Intestinal soluble
Total carotenoids Einkorn 4.70
a
 ± 0.08 3.65
a
 ± 0.08
30% buckwheat 3.49
b
 ± 0.24 2.71
b
 ± 0.12
30% amaranth 2.79
c
 ± 0.13 2.36
c
 ± 0.01
30% quinoa 3.34
bc
 ± 0.26 2.80
b
 ± 0.04
Bread wheat 1.05
d
 ± 0.00 0.68
d
 ± 0.05
Total tocols Einkorn 77.7
a
 ± 2.2 53.3
a
 ± 2.5
30% buckwheat 75.3
ab
 ± 3.4 51.6
a
 ± 0.3
30% amaranth 66.4
c
 ± 0.6 43.8
b
 ± 0.9
30% quinoa 69.4
bc
 ± 2.4 49.8
a
 ± 1.6
Bread wheat 56.0
d
 ± 0.5 32.9
b
 ± 0.0
TPP Einkorn 1627.6
c
 ± 44.5 8131.5
a
 ± 242.8
30% buckwheat 2697.1
a
 ± 21.5 6963.8
b
 ± 38.6
30% amaranth 1690.8
c
 ± 43.0 5954.2
c
 ± 19.6
30% quinoa 1895.9
b
 ± 14.9 5700.3
c
 ± 24.6
Bread wheat 991.3
d
 ± 12.2 6593.6
b
 ± 190.3
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In the case of undigested WBs, phenolic acids determination was evaluated both for the soluble 
conjugated and the insoluble bound fraction (Tab. 2). The soluble free phenolic acids were 
always below the detection limit. The total phenolic acids was the sum of different identified 
compounds: ferulic, p-coumaric, vanilic, p-hydroxybenzoic and syringic acids. In undigested 
WBs the insoluble bound fraction was always higher than the soluble conjugated one. 
Furthermore, the einkorn-enriched WBs showed higher soluble conjugated and lower insoluble 
bound phenolic acids content compared with einkorn and bread wheat WBs (P<0.05). After 
gastrointestinal digestion, the total amount of soluble conjugated fraction of phenolic acids 
increased in each WB, while the insoluble one decreased. Also for WB digestates, the enriched 
ones were richer in soluble conjugated phenolic acids than the two control WBs (einkorn and 
bread wheat, Tab. 2).  
Table 2 | WBs and their digestates content of soluble conjugated and insoluble bound phenolic acid fractions. 
Significant statistical differences between WB samples were marked with different letters. Results were expressed 
as mg/kg DM and a P<0.05 was considered significant. [122] 
Finally, the potential antioxidant capacity of WBs and their digestates were evaluated in test 
tubes, without the presence of cells. FRAP results showed that undigested einkorn-enriched 
WBs had significantly higher antioxidant activity than the control WBs (P<0.05). After 
gastrointestinal digestion the antioxidant activity of each WB digestate increased but there were 
no significative differences among the different WB digestate FRAP values (Tab. 3).  
Insoluble bound Soluble conjugated Insoluble bound Soluble conjugated 
Phenolic acids Einkorn 779.9
a
 ± 10.3 62.2
c
 ± 2.6 665.7
a
 ± 1.2 89.8
c
 ± 2.1
30% buckwheat 652.3
c
 ± 6.6 84.3
b
 ± 0.2 575.3
c
 ± 1.0 100.6
b
 ± 4.0
30% amaranth 625.0
cd
 ± 12.5 69.7
c
 ± 3.5 571.4
d
 ± 1.0 92.3
bc
 ± 0.7
30% quinoa 589.3
d
 ± 11.1 92.7
a
 ± 1.8 392.4
e
 ± 1.2 111.0
a
 ± 2.9
Bread wheat 736.8
b
 ± 9.1 51.5
d
 ± 0.5 590.6
b
 ± 1.1 89.2
c
 ± 1.0
Digestate
Sample
Water biscuit
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Table 3 | WB and their digestates antioxidant capacity. Significant statistical differences between WB samples 
were marked with different letters. FRAP results were expressed as mmol TE/kg DM and a P<0.05 was considered 
significant. [122] 
Co-culture viability after WB digestates administration  
Figure 2 | WB digestates effect on co-culture viability. Statistical significative differences among 1x and 10x 
digestate doses and CTRL (not treated cells) were indicated using different letters. P<0.05 was considered 
significant. [122] 
Co-culture viability was evaluated after WB digestates administration at the physiological dose 
(1x) and at ten, fifty and one hundred times higher (10x, 50x and 100x, respectively); the last 
Sample Water biscuit Digestate
FRAP Einkorn 5.9
c
 ± 0.1 23.2 ± 1.5
30% buckwheat 12.5
a
 ± 0.2 23.3 ± 1.1
30% amaranth 8.3
b
 ± 0.3 22.6 ± 0.6
30% quinoa 8.7
b
 ± 0.4 23.1 ± 0.9
Bread wheat 3.8
d
 ± 0.0 20.8 ± 0.4
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dose corresponded to the one used for FRAP antioxidant activity assay. Viability results showed 
a dose dependent decrease until cell detachment at 50x and 100x dose (data not showed) for 
each considered digestate. The trypan blue assay revealed that cell detachment was due to cell 
death, this effect was not observed when cells were treated only with BD at the same doses. 
The 1x dose significantly reduced cell viability only in the case of einkorn (P<0.01) and 
enriched WB with quinoa (P<0.05) and amaranth (P<0.01), while the 10x dose of each WB 
digestates significantly reduce (P<0.01) cell viability (Fig. 2), although it was not toxic. 
WB digestates antioxidant activity evaluation 
Figure 3 | WB digestates antioxidant activity in co-culture cells. In the graphs, each bar corresponded to the 
CAA mean value ± SD vs not treated cells (CTRL, CAA units = 0). WB digestates were administered at 1x and 
10x doses both alone or in presence of AAPH. GLUT and GLUT + AAPH were used as antioxidant contros while 
AAPH alone as the oxidative control. Statistical significative differences among digestate doses + AAPH vs AAPH 
alone were indicated using different letters. P<0.05 was considered significant. [122] 
 
67 
 
In order to evaluate the WB digestates antioxidant capacity on living cells, the CAA assay was 
performed using only the not toxic 1x and 10x doses (Fig. 3). The 50x and 100x doses caused 
cell death and detachment from their growth support, as revealed by the MTT assay (data not 
showed), for this reason were not used for the CAA assay. Each digestate was administered 
alone or in presence of AAPH, a molecule able to produce spontaneously ROS. WB digestates 
showed a slighter and not significant oxidative effect both at 1x and 10x dose than control cells 
(x axis, CAA units = 0), the same behaviour was observed after BD administration (Fig. 3).  
CAA units of 1x dose administration in presence of AAPH showed values similar to AAPH 
administration alone, except for quinoa-enriched WB digestate which showed a significative 
CAA value decrease compared to the AAPH effect (P<0.01, Fig. 3). WB digestates at the 10x 
dose + AAPH always showed a significative decrease of CAA values compared to AAPH alone 
(P<0.01), this ROS reduction effect was the same for each digestate (Fig. 3). In the case of BD 
administration at 1x and 10x dose + AAPH, CAA values were always similar to those of AAPH 
alone. The administration of GLUT and GLUT+AAPH resulted in the expected antioxidant 
activity (positive CAA values).  
3.3.2 Bread samples results 
Physical and chemical characteristics of bread doughs and samples  
The final leavening doughs chemical proprieties were compared in Tab. 4. As expected, doughs 
obtained by LABs fermentation presented significantly lower pH values and consequently 
higher TTA values than SC dough (P<0.05).  
Table 4 | SC and LAB doughs chemical characteristics. Significative differences between bread dough samples 
were marked with different letters for each feature. A P<0.05 was considered significant. [123] 
Leavening/Fermentative 
microorganisms
pH
TTA                            
(mL NaOH 0.1 M/10 g)
SC 5.83±0.02
e
3.40±0.10
a
BT124 4.60±0.02
c
5.15±0.08
c
BT117 4.41±0.01
a
6.01±0.07
d
LF16 4.97±0.01
d
4.70±0.20
b
LR12 4.57±0.05
b
5.42±0.08
c
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These differences were not related to the bread physical properties (Fig. 4).  
Figure 4 | Bread slices produced by SC or LABs fermentation activity [123] 
The SC leavening ability produced the highest bread specific volume compared with all the 
LAB breads (P<0.05). LF16 and LR12 showed the same lowest CO2 production capacity, 
therefore, the corresponding breads exhibited a specific volume significantly lower than BT117 
and BT124 ones (P<0.05). At the same time, the BT117 fermentation properties induced the 
production of a bread with a specific volume significantly higher than the one produced by 
BT124 (P<0.05). Specific volume and moisture of each bread sample were summarized in Tab. 
5. 
Table 5 | SC and LAB breads physical characteristics. Significative differences between bread samples were 
marked with different letters for each physical feature. A P<0.05 was considered significant. [123] 
Regarding the presence of phytates in bread samples, results showed that only the LR12 
fermentation activity significantly reduced the presence of phytates compared with the SC 
leavening activity (P<0.05). The phytic acids concentration was 0.0948 ± 0.003 g/100 g for SC 
and 0.0806 ± 0.003 g/100 g for LR12. Phytates concentration in LF16, BT124 and BT117 
breads did not differ from the values found in SC and LR12 ones. 
Leavening/Fermentative 
microorganisms
Moisture (%) Weight (g) Volume (mL) Specific Volume (mL/g)
SC 40.12±0.01
b
215±1
a
588±10
d
2.73±0.04
d
BT124 39.73±0.01
b
219±1
b
359±32
b
1.60±0.20
b
BT117 39.64±0.01
b
221±1
b
420±8
c
1.90±0.03
c
LF16 36.77±0.01
a
219±1
b
240±12
a
1.09±0.06
a
LR12 36.59±0.01
a
216±1
a
233±17
a
1.07±0.08
a
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Starch hydrolysis before and after breads in vitro digestion  
Table 6 | SC and LAB bread samples and digestates content of maltotriose, maltose and glucose. Significative 
differences among bread samples ante or post in vitro gastrointestinal digestion were marked with different letters 
for each considered sugar. A P<0.05 was considered significant. [123] 
The degree of starch hydrolysis obtained both after SC or LABs fermentation and after the in 
vitro digestion process was evaluated using maltotriose, maltose and glucose as an index of 
amylolysis and were summarized in Tab. 6. The total amount of these sugars in LAB bread 
samples was significantly higher than in SC bread (P<0.05), while after in vitro digestion SC 
bread digestate showed the highest level of total simple sugars derived from starch hydrolysis.  
The RDS and SDS starch fractions were evaluated in bread samples (Fig. 5). Although values 
of RDS and SDS, expressed as % vs available starch in bread samples, did not show any 
significant differences, BT124 bread displayed the lowest RDS value and the higher SDS value. 
SUGAR               
(g/100 g d.m.) 
SC BT117 BT124 LR12 LF16 
maltotriose 
     ante digestion 0.08±0.01h 0.34±0.02g 0.65±0.02e 0.61±0.03e 0.43±0.01f 
post digestion 5.46±0.15b 4.35±0.38d 5.31±0.19c 5.38±0.35bc 5.75±0.41a 
maltose 
     
ante digestion 2.32±0.02g 2.57±0.02ef 2.51±0.03e 2.63±0.04f 2.22±0.03h 
post digestion 42.05±0.65a 33.94±0.25d 37.84±0.29c 37.66±0.21c 39.69±0.15b 
glucose 
     
ante digestion 0.11±0.02h 0.06±0.00i 0.21±0.01g 0.31±0.01e 0.26±0.01f 
post digestion 8.19±0.27a 6.78±0.13d 7.63±0.24b 7.41±0.31c 7.64±0.15b 
total 
     
ante digestion 2.51±0.05h 2.97±0.04g 3.37±0.06f 3.55±0.08e 2.91±0.04g 
post digestion 55.70±1.07a 45.07±0.76d 50.78±0.72b 50.45±0.87b 53.08±0.71c 
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Figure 5 | Effect of SC and LAB fermentation on starch hydrolysis. In the graph, black bars correspond to the 
RDS while grey bars to the SDS. Results were expresses ad % vs available starch in bread samples. [123] 
Co-culture viability after bread digestates administration  
The presence of each bread digestates at the physiological dose in the culture medium did not 
alter the co-culture cell viability compared to the non-treated (CTRL) cells (Fig. 6). Since 
digestates showed a non-toxic effect on cells, they were used to perform the other cell-based 
experiments. 
Figure 6 | Effect of SC and LAB bread digestates on cell viability. In the graph, each bar corresponds to the % 
of cell viability vs not treated cells (CTRL, 100%). [123] 
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Co-culture paracellular permeability after bread digestates administration  
The effect of SC or LABs presence and leavening/fermentation activity in bread digestates on 
co-culture paracellular permeability was evaluated measuring TEER.  
Figure 7 | Effect of SC and LAB bread digestates on co-culture permeability. In the graph, each bar 
corresponds to the % of TEER vs not treated cells (CTRL, 100%). Statistical significative differences among 
digestates were indicated using different letters (P<0.05). [123] 
TEER values obtained after each bread digestates administration did not differ from CTRL 
(not-treated cells). The only significative difference in TEER values was revealed comparing 
BT124 and BT117 digestates: BT117 administration significantly reduced TEER compared 
with the BT124 effect (P<0.05, Fig. 7).  
Co-culture PYY secretion after bread digestates administration  
In order to evaluate whether the presence of SC or different LABs and their 
leavening/fermentation capacities can induce the production of breads with different satiety 
properties, the co-culture PYY release after bread digestates administration was evaluated.  
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Figure 8 | Effect of SC and LAB bread digestates on co-culture PYY production. Statistical significative 
differences among digestates were indicated using different letters (P<0.01), while significative differences 
between digestates and CTRL cells (100%) were marked with an asterisk (P<0.01). [123] 
PYY production induced by LAB bread digestates administration showed values very closer to 
the CTRL one; the significant differences revealed by statistical analysis among values were 
due to the low SD associated to each value (Fig. 8). These differences were not significant from 
the biological point of view. In the case of SC bread digestate administration, PYY production 
was significantly higher both than control cells (CTRL) and the LAB bread digestates (P<0.01). 
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3.4 DISCUSSION 
3.4.1 WBs and their digestates  
In the last years, people attention was focused on nutraceuticals, functional foods or food rich 
in antioxidant compounds due to their preventive effect on chronical, aging-related and 
inflammatory diseases onset [68, 69]. Among foods, there are different types of underutilized 
crops, such as einkorn, quinoa, amaranth and buckwheat, rich in antioxidant compounds like 
carotenoids, tocols, phenolic acids and polyphenols [124, 125]. Flours derived from these 
cereals and pseudocereals can be used to produce bakery products, which are the most 
consumed food worldwide, with additional bioactive proprieties to improve human health and 
prevent diseases related to oxidative stress and excessive ROS production. However, once 
ingested, little evidences are available about both the release, bioavailability and activity of 
these antioxidant molecules after gastrointestinal digestion, and the effect of these digestates 
containing bioactive compounds on the human intestinal epithelium. Based on these 
considerations derived the necessity to study in vitro the bioavailability of these antioxidant 
compounds after digestion and their effect/interaction with the intestinal epithelium, where 
these compounds can, as a first step, exert their antioxidant activity once digested. Therefore, 
the aim of this study was to investigate the release and bioavailability of carotenoids, 
polyphenols, phenolic acids and tocols after in vitro gastrointestinal digestion [108] of five WBs 
obtained using different cereal and pseudocereal flour mixtures (as described in paragraph 
3.2.1 of Material and methods section), and the possible WB digestates cytotoxic and 
antioxidant activity on the co-culture cells model [95]. 
The total carotenoids content found in undigested WBs where consistent with that found in the 
used whole flours (5.6, 3.3, 1.4, 1.74 mg/kg DM and below the detection limit, respectively in 
einkorn, buckwheat, quinoa, wheat and amaranth) and taken into account the carotenoid 
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degradation due to the WBs production process [111]. As observed for carotenoids, also tocols 
content in undigested WBs reflected those found in the starting whole flours (72.0, 86.2, 39.6, 
66.3 and 64.2 mg/kg DM respectively in einkorn, buckwheat, quinoa, amaranth and wheat). 
Once digested, the total amount of soluble carotenoids and tocols was lower than the quantity 
present in the corresponding undigested WBs but somehow correlated. In fact, the larger was 
the quantity of carotenoids and tocols in the undigested WBs the higher was their concentration 
in the intestinal soluble digestates fraction. Thus, einkorn WB and its digestate showed the 
highest carotenoids and tocols content as a consequence of the highest amount in the starting 
whole flour, while bread wheat WB and its digestate showed the lowest content of these two 
compounds. These observations were in agreement with those of Read et al. 2015 [126]. 
Concerning the phenolic acids, the most represented fraction was the insoluble bound both in 
undigested WBs and in their digestates, but this fraction is characterized by a low bioavailability 
and, as a consequence, is not significative from a nutritional point of view. The highest content 
of soluble conjugated fraction was found in einkorn-enriched WBs that reflect the high content 
of these compounds in the pseudocereals seeds [125, 127]. After in vitro gastrointestinal 
digestion, the soluble conjugated fraction increased in each WB digestates indicating a partial 
conversion of the insoluble bound fraction in the soluble conjugated one due to the digestion 
process. This observation suggested that digestion could increase bioavailability of phenolic 
acids soluble conjugated fraction. Finally, the TPP content showed a considerable increase in 
each WB digestates thus indicating that the digestion process increased TPP bioavailability. 
This effect was just observed also after the digestion of buckwheat-enriched bread, amaranth-
enriched biscuits and in cooked millet [128-130].   
After the characterization of all WB samples, the following step was to understand if the 
potential antioxidant activity of the WB antioxidant compounds was maintained after in vitro 
digestion. The theoretical antioxidant activity, evaluated by FRAP assay in test tubes, was the 
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same for each WBs digestates. Subsequently, to validate the antioxidant data obtained from 
FRAP assay, WB digestates were administered to the co-culture model at the four different 
doses (1x, 10x, 50x and 100x) first tested for their possible cytotoxic effect. Interestingly, the 
100x dose of each WB digestates showed an important antioxidant activity using the FRAP 
assay but was toxic for the co-culture model. This observation highlights the necessity to always 
consider and use, for this type of experimental studies, the physiological quantity of food that, 
after ingestion, comes into contact with a specific area of the intestine, an excess could lead to 
cells death instead of positive effects. At the same time, it is fundamental to compare the 
bioactivity data obtained in test tubes for a specific molecule with the ones obtained using the 
specific in vitro cell model. As a consequence, the FRAP values were compared with the CAA 
assay values obtained from the WB digestates administration at 1x and 10x dose which are not 
toxic. CAA values showed that each WB digestates at 10x was able to reduce the oxidative 
stress generate by AAPH presence. Only quinoa-enriched WB digestate acted as a ROS 
scavenger at 1x dose supporting the greater antioxidant potential of this pseudocereal [125]. 
Overall, these cellular based antioxidant results showed the ability of WBs to act as ROS 
scavenger and as a consequence their potential beneficial effect on cell damages prevention 
induced by oxidative compounds. 
In conclusion, this study supports the potential positive effect of underutilized cereals and 
pseudocereals rich in antioxidant compounds against pro-oxidative damages, thanks to their 
ROS scavenging activity, which was maintained also after gastrointestinal digestion.  
3.4.2 Breads and their digestates  
In Europe, one of the most consumed food, as a source of carbohydrates, is bread usually 
produced using the Saccharomyces cerevisiae (SC) leavening capacity [131]. This SC ability 
is fundamental to obtain tasty, value-added and soft bakery products starting from cheap 
ingredients such as wheat flour and tap water [132]. However, this continuous exposition to 
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bakery products containing SC, as leavening agent, can lead to sensitization and develop of 
anti-SC autoantibodies that induced, in susceptible individuals, the onset of allergic symptoms 
[133-135]. The best method to avoid this reaction is to completely exclude from daily diet all 
the SC containing products [136, 137]. However, this restrictive diet can be characterized by a 
low compliance from people whose feeding is based on this kind of leavening food products. 
This consideration has led to develop baking products exploiting the fermentative properties of 
LABs. These microorganisms are just present, alongside SC, in sourdough, which is a 
fermented preparation composed by flour and water normally used as a starter for dough 
leavening [138, 139]. The fermentative activity of LAB is involved not only in dough leavening, 
acidification and formation of flavour but can also being implicated in formation of potential 
bioactive peptides. In fact, the LAB proteolytic activity is responsible for the release of 
antioxidant, anti-hypertensive and antitumoral peptides from cereal proteins [140-142]. In 
addition, LAB own enzymes able to degrade phytic acid improving mineral bioavailability 
[143]. 
Based on these considerations, the aim of this study was to compare the physical, chemical, 
nutritional and health-improving proprieties of five breads and their in vitro digestates obtained 
from four different LAB strains (BT124, BT117, LF16 and LR12) or SC used as leavening 
agents. 
The specific volume of breads obtained by LABs fermentation was always lower than SC bread 
specific volume, thus indicating that LABs were not able to produce an amount of CO2 
comparable to SC. Anyway, BT124 and BT117 bread specific volumes were similar to the one 
previously observed in rye bread [144] and were indicative of a bread crumb enough soft to be 
eaten. At the same time, the phytate amount in LAB breads were always lover than SC bread, 
this probably is an indirect effect due to LAB fermentation activity. In fact, phytate degradation 
in dough is normally attributed to cereal phytases that enhance their activity in acid conditions. 
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LAB doughs showed pH values in a range of 4.41-4.97 therefore, the reduced presence of 
phytate in LAB breads might be due to this acidification activity [145]. Phytate are known to 
form insoluble complexes with divalent cations reducing the absorption of these essential 
minerals and are not easily degradable at pH higher than 5 [146]. LABs fermentation activity 
reducing phytate concentration improves the nutritional value of bread.   
Furthermore, the LAB starch hydrolysis activity resulted in a higher presence of simple sugars 
in LAB bread samples than in SC bread, although amylase activity was found only in few LAB 
strains. These effects could be due to glucosidase activity, which is reported in different LAB 
strains [147]. Similar values of simple sugar released by LABs fermentation, but also bread 
doughs pH and acidity values, were just found in breads produced using a sourdough containing 
both LABs and SC [148]. Furthermore, the level of maltose and glucose in bread obtained by 
SC fermentation were comparable to those previously reported for wheat bread [149]. Together 
with LAB bread simple sugar content, the evaluation of RDS and SDS were fundamental to 
study the impact of LABs fermentation on the bread Glycemic Index (GI). In vitro studies have 
found a strong correlation with GI and the starch hydrolysis; RDS and SDS represent the starch 
fraction that is likely to be completely digested and absorbed in the human small intestine while 
the remaining part of starch, named resistant starch (RS), is available for fermentation in the 
colon with a potential beneficial effect on human health (i.e. butyrate production) [150]. RDS 
and SDS fractions were adopted to evaluate the food glycemic response. In fact, consumption 
of cereal products high in SDS induced a lower glycemic response after a meal than cereal 
products low in SDS [151]. The highest amount of SDS and the lowest RDS fraction showed 
in BT124 bread sample suggested the lowest glycemic response once ingested. This hypothesis 
was supported also by the low total amount of simple sugar released after the in vitro 
gastrointestinal digestion of BT124 bread, a feature shared by the other three LAB breads. 
Different papers showed a correlation between the increasing acidity of sourdough, obtained by 
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LAB or organic acids addition, and the reduction of the bread GI [152]. This correlation could 
be due to the formation of starch-protein complexes which prevent starch hydrolysis [153] or 
to the delay of gastric empty observed in rats and humans after ingestion of breads with the 
above described chemical characteristics.  As expected, SC bread which showed the highest pH 
value (5.83) and the lowest acidity (3.4 mL NaOH/10g) compared with LAB breads, exhibited 
the highest starch hydrolysis. 
Once characterized, breads and their digestates were assessed for their satiety capacity, a further 
potential beneficial effects on human health. In the human intestine there are endocrine cells 
able to produce anorectic hormones, such as PYY, cholecystokinin and glucagon-like peptide 
1, when come into contact with food macromolecules after a meal. These hormones, once 
secreted, are able to improve digestion and absorption processes by means of gastric empty 
inhibition and pancreatic enzyme secretion [154]. They also enter into the bloodstream, reach 
the brain where the central nervous system center that controls appetite is localized and induce 
satiety [155]. Overall, these effects induce satiety onset and food consumption reduction. As a 
consequence, the food satiety capacity together with its glycemic response can affect human 
health and the obesity onset. This study was focused on the potential release of PYY by co-
culture cells. Once assured that bread digestates administration were not able to affect co-
culture cell viability and permeability, the PYY secretion induced by bread digestates was 
evaluated. Differently from the other anorectic hormones, PYY was resistant to proteases 
hydrolysis and its concentration remains elevated until sixth hours from food ingestion. 
Furthermore, PYY plasma concentration depends on calories and proteins presence in the meal 
[156]. The highest co-culture PYY secretion obtained after SC bread digestate administration 
could be thus explained by the highest simple sugar concentration and, as a consequence, the 
highest caloric content found in this digestate.  
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Taken together these data represent the first proof in literature that breads obtained only by 
LABs leavening activity could be used to prepare alternative bakery products able to improve 
human health increasing mineral bioavailability and reducing the glycaemic response. At the 
same time, LABs fermentation activity did not produce molecules that affect the viability and 
permeability features of the intestinal cells and was not able to induce satiety, probably due to 
the lower released of total simple sugars from starch. This study represents the first attempt to 
create competitive and alternative bakery products only with LAB strains. Further analysis will 
be aimed to prepare bakery products including the best nutritional features derived from 
different LAB strains fermentation. 
80 
 
 
 
 
Chapter 4 
 Development of an in vitro cellular 
model of overweight/obese intestine  
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4.1 AIM 
As previously described in Chapter 1, several studies have shown that the introduction of an 
excessive quantity of nutrients with the diet can profoundly modify the morpho-functional 
characteristics of intestinal epithelium in vivo and, at the same time, induce the onset of an 
inflammatory process. Unfortunately, no data were reported by in vitro studies on human 
intestinal cell models. 
Based on these observations, the aim of this part of my project was to evaluate, for the first time 
in vitro, whether the presence of high amounts of nutrients can modify the morpho-functional 
characteristics of an intestinal cell model. The intestinal cell model used for this study was the 
70/30 Caco2/HT-29 co-culture, well-described and characterized in Chapter 2, while the excess 
of nutrients was obtained increasing the frequency of medium administration respect to the 
normal protocol of medium change. The effects of this nutrient excess on the co-culture 
morpho-functional features were evaluated, at different post-confluence days, with the 
following experiments: i) morphological analysis and mucus secreting cell staining to evaluate 
the presence and localization of absorbent and mucus secreting cells, and the junctional 
apparatus; ii) functional analysis to evaluate ALP, APN and DPP IV activity, which are 
indicative of intestinal cell differentiation, and permeability and integrity of the TJ using TEER 
and LY; iii) evaluation of the co-culture inflammatory status by measuring ROS and NO 
intracellular production and secretion of inflammatory cytokines; iv) assessment of the PYY 
anorectic hormone release. The experimental procedure here used to grow the co-culture could 
be useful to set up an in vitro intestinal model for studying the molecular mechanisms at the 
base of the intestinal obese phenotype development and, at the same time, to evaluate for the 
first time in vitro the effects of different medium change protocols on the features of the 
considered in vitro intestinal cell model.  
82 
 
4.2 MATERIALS AND METHODS 
All cell culture media and reagents were from Sigma-Aldrich (St. Louis, MO, USA). Fetal 
Bovine Serum (FBS) was from EuroClone Ltd (West Yorkshire, UK). 
4.2.1 In vitro model of human intestinal epithelium 
The in vitro intestinal cell model used for each experiment is the 70/30 Caco2/HT-29 co-culture 
[95], deeply described and characterized in Chapter 2. Co-culture was seeded in complete 
RPMI at 40.000 cells/cm2 density for all the experiments, always kept at 37°C and 5% CO2 - 
95% air atmosphere and periodically checked for the presence of mycoplasma or bacterial 
contaminations. 
4.2.2 Medium change protocols 
The administration of different quantity of nutrients was mimed using three protocols of 
medium change (schematized in Fig. 1) with the following characteristics:  
1) Standard (ST) protocol represented the nutrient amount supplied to cells under normal 
culture conditions. Medium was completely replaced every 4 days. 
2) Intermediate (IN) protocol provided an intermediate quantity of nutrients than those 
provided under Standard and Excess conditions. Medium was replaced every 2 days, but a 
complete medium change was alternated with the change of only half of cell medium. 
3) Excess (EX) protocol provided an excess of nutrients than those normally provided under 
ST culture conditions by increasing the frequency of medium change. Medium was 
completely replaced every 2 days. 
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Figure 1 | Administration plan of the three medium change protocols (ST, IN and EX) to co-culture. Time 
axis numbers represent the days from the confluence (0), at the same time, squared numbers indicated the analysed 
time points. Time axis show: i) complete medium changes (black circles) for ST protocol, ii) complete medium 
changes (black circles) and half medium changes (black rhombus) for IN protocol; iii) complete medium changes 
(black circles) for EX protocol. [157] 
ST, IN and EX protocols were applied starting from cell confluence (T0) and the co-culture 
morpho-functional features were analyzed after 3 (T3), 7 (T7), 11 (T11) and 15 (T15) days 
from confluence.  
4.2.3 TEM analysis and PAS/Alcian blue staining 
Protocols used to perform these experiments were the same used to characterize the co-culture 
morphological features and were described in the paragraphs 2.2.2 and 2.2.3 of Chapter 2 in 
Material and Methods section. 
TEM analysis and PAS/Alcian blue staining were performed in collaboration with Prof.ssa 
Elena Donetti, Department of Biomedical Sciences for Health, University of Milan. 
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4.2.4 Trypan blue assay for proliferation rate assessment 
The evaluation of the co-culture proliferation rate was performed using the Trypan blue assay 
[119]. The living cell number was calculated, for each time point of the three medium change 
protocols, as follows: co-culture cells were seeded in a 24 well plate (Greiner bio-one 
CELLSTAR ®, Italy) in 1 ml of complete RPMI and allowed to growth until the time point of 
interest. At the desired post-confluence day, 400 µL of trypsin-EDTA was used to remove cells 
from their growth support, its action was stopped adding, in each well, 1 ml of complete RPMI, 
and samples were collected in separated eppendorfs. To count only the number of living cells 
using a burker chamber, dead cells were first stained with trypan blue and the uncoloured living 
ones were counted. Values were expressed as n° of living cells/cm2 of growth support area. 
4.2.5 P2 fraction isolation and ALP, DPP IV, APN specific activity assay 
The functional features of the brush border enzymes, indicative of intestinal cell differentiation, 
were evaluated using the protocols described in paragraphs 2.2.5-2.2.8 of Chapter 2 in Material 
and Methods section. 
4.2.6 Permeability analysis (TEER and LY Papp) 
The co-culture permeability features, with days in culture for each applied protocol of medium 
change, were monitored using the protocols described in paragraph 2.2.9 of Chapter 2 in 
Material and Methods section, with minor modification for the LY Papp evaluation. Briefly, LY 
Papp was evaluated, only for T6 and T15 of each protocol, after a 2 h co-culture incubation with 
LY. Furthermore, TEER values were expressed as Ω·cm2·105 cells, this data format considered 
the differences in the co-culture proliferation rates due to the administered protocol. 
4.2.7 NO production assay 
The co-culture NO intracellular production due to the three applied protocols, at each time 
point, was evaluated using the procedure described by Balcerczyk et al. (2005) and Viani et al. 
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(2001) [158, 159], with some modifications. Co-culture cells were seeded into a 96-well black 
plate (Greiner bio-one CELLSTAR ®, Italy) in complete RPMI. At the desired time point, 
medium was discharged, cells were washed with 100 μL of PBS and incubated with 100 μL of 
HBSS containing 10 mM Hepes and 40 μM diaminofluorescein-FM diacetate (DAF-FM DA). 
After 1 h incubation, the probe was deacetylated, entrapped in the cytoplasm and emitted 
fluorescence (λex= 500 nm; λem = 515 nm) when interact with intracellular NO. Fluorescence 
was measured immediately and after 120 min incubation by a Wallac Victor2 1420 Multilabel 
Counter plate reader (Perkin Elmer, UK). Values of AUF obtained after 120 min were expressed 
as the average daily production of NO by 105 cells, calculated as reported in 4.2.10 paragraph, 
this data format considered the different co-culture proliferation rates and the timing of medium 
administration of the three protocols. 
4.2.8 ROS production assay 
The co-culture ROS intracellular production due to the three applied protocols, at each time 
point, was evaluated using the CAA Assay described in paragraph 3.2.7 of Chapter 3 in 
Material and Methods section, with minor modifications. In order to evaluate changes in the 
co-culture basal oxidative status, cells were only incubated with the solution of HBSS (10 mM 
Hepes) containing 60 μM DCFH-DA without the addition of AAPH. After 20 min incubation 
with the probe, the emitted fluorescence was evaluated immediately and after 120 min. Values 
of AUF obtained after 120 min were expressed as the average daily production of ROS by 105 
cells, calculated as reported in 4.2.10 paragraph, this data format considered the different co-
culture proliferation rates and timing of medium administration of the three protocols. 
4.2.9 Cytokines and PYY production assay 
In order to evaluate the co-culture secretion of IL-6, IL-8 and PYY in the culture medium due 
to the different medium change protocols, cells were seeded in 75 cm2 Flasks (Greiner bio-one 
CELLSTAR ®, Italy) in complete RPMI. At each time point, medium was collected in separate 
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eppendorfs, centrifuged to remove any cells presence in suspension and conserved at -80°C. 
Medium was used to measure the IL-6 and IL-8 production by a magnetic Luminex 
performance assay, while PYY secretion by an ELISA kit. These assays were performed by 
LABOSPACE s.r.l. (Milan, Italy). Values obtained were expressed as the average daily 
production of IL-6, IL-8 ad PYY by 105 cells, calculated as reported in 4.2.10 paragraph, this 
data format considered the different co-culture proliferation rates and timing of medium 
administration of the three protocols. 
4.2.10 Statistical analysis 
Figure 4-8 showed the mean values ± SD from at least three independent experiments, each of 
them composed by almost three replicates. The SPSS 20 statistical software (SPSS, Chicago, 
IL, U.S.A.) was used to reveal whether mean values were statistically different either among 
the three protocols at the same time point or for one protocol at different time points.  The 
significative differences where evaluated for both cases by One-way ANOVA, followed by a 
Bonferroni post hoc t test. The level of significance was considered P<0.05 and was 
represented using different letters for one protocol with days in culture or symbols among the 
three different protocols at the same time point. In the case of ROS, NO, IL-6, IL-8 and PYY 
production the obtained results (AUF = Arbitrary Units of Fluorescence or pg) were 
normalized as follows: 
 
The calculated production by 105 cells was then divided by a number that represent the days 
during which the growth medium and co-culture cells remained in contact before each time 
point of the three protocols: 4 for ST; 2 for IN and 1 for EX. This procedure was fundamental 
to calculate the average daily production by 105 cells. 
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4.3 RESULTS 
4.3.1 Morphological characteristics 
TEM analysis revealed that co-culture was always arranged in a multilayer for each protocol, 
but at T15 the multilayer was more evident only for EX (Fig. 2A, D, G, J and Tab. 1). Microvilli 
development, and therefore the presence of differentiated enterocytes, started from T3 in the 
case of ST and IN (Fig. 2Ae B) that showed the presence of short and scattered microvilli, but 
they were almost absent in EX (Fig. 2C). At T7 a well-developed brush border was present for 
each protocol (Fig. 2D-F), followed by a reduction in their density and length at T11 that 
remained stable until T15 for EX and IN (Tab. 1). In the case of ST, images showed an 
important increase of microvilli presence at this last time point (Tab. 1). The same behaviour 
was showed by cell junction development that was more evident at T7 with a reduction at T11 
for each protocol (Tab. 1). Important differences were found at T15 were the junctional 
apparatus was considerably well-developed for ST (Fig. 2J), while disappeared in the case of 
EX. Finally, FLS appeared at T3 for EX and IN and at T7 for ST remaining stable with days in 
culture except in the case of IN at T11 and EX at T15 (Fig. 2L) where they became particularly 
evident.  
The PAS/Alcian Blue staining revealed the presence of mucus secreting cells for each group at 
different post-confluence days (Fig. 3). Images showed the mucus-secreting phenotype stained 
in reddish-violet, while the non-mucus-secreting one was evidenced by a bluish cytoplasmic 
background. Mucus-secreting cells were present in few amounts in all the three groups at T3 
(Fig. 3A-C), followed by a considerable increase at T7 (Fig. 3D-F).  
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Figure 2 | TEM images of co-culture subjected to ST, IN and EX medium change protocols at different post-
confluence days. Representative microphotographs of ST, IN and EX co-culture at T3 (A, B, C), at T7 (D, E, F), 
at T11 (G, H, I) and at T15 (J, K, L). Bars: 2 µm and 500 nm (only for B); Microvilli, cell junction and FLS were 
indicated respectively by arrows, asterisks and arrowhead. [157] 
At T11 mucus production remained evident in EX (Fig. 3I) and IN (Fig. 3H) group, while it 
was reduced in ST (Fig. 3G). After fifteen days of post-confluence, mucus disappeared in ST 
(Fig. 3J), decreased in IN (Fig. 3K) and remained stable in EX (Fig. 3L). 
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Figure 3 | PAS/Alcian blue staining of co-culture subjected to ST, IN and EX medium change protocols at 
different post-confluence days. Representative microphotographs of ST, IN and EX co-culture at T3 (A, B, C), 
at T7 (D, E, F), at T11 (G, H, I) and at T15 (J, K, L). Bars: 50 µm. [157] 
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Table 1 | Ultrastructure features of co-culture subjected to ST, IN and EX medium change protocols at 
different post-confluence days. The presence or the absence of a particular cell structure was indicated with + or 
-, respectively. [157] 
4.3.2 Proliferation features 
Co-culture proliferation rate responded differently to the three protocols of medium change 
(Fig. 4A). In the case of ST, the number of living cells slowly but continuously increased until 
T15, while IN group reached the maximum value at T7, followed by a plateau. Finally, the EX 
group proliferation rate significantly increased until T11 but was followed by a significative 
drop to IN values at T15. The EX living cell number was always significantly higher than ST, 
while only until T11 if compared with IN group. At the same time, the proliferation rate of ST 
was significantly lower than IN from T7 to T15. The co-culture protein content (Fig. 4B) 
continuously and significantly increased for each protocol from T3 to T15. At each time point, 
EX and ST displayed the highest and the lowest value respectively. Significative differences 
T3 T7 T11 T15
ST + + + ++
IN ± + ± +
EX + + + ±
T3 T7 T11 T15
ST ± + ± ++
IN ± + ± ±
EX - + ± ±
T3 T7 T11 T15
ST ± + ± ++
IN ± ++ - +
EX - + ± -
T3 T7 T11 T15
ST - + ± +
IN ± ± ++ +
EX + + + ++
MULTILAYER
MICROVILLI
CELL JUNCTIONS
FOLLICLE - LIKE STRUCTURES
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among groups at the same time point or for a single protocol with days in culture showed the 
following level of significance: P<0.01.  
Figure 4 | Number of living cells and protein content of co-culture subjected to ST, IN and EX medium 
change protocols at different post-confluence days. Number of living cells on cm2 of growth area (A) and H 
protein content (B) were determined at each time point. Statistical significative differences (P<0.01) among the 
different protocol mean values, at the same post-confluence day, were marked with different symbols (*, § and °). 
Mean values assumed by one protocol, at different time points, were marked with progressive letters when showed 
a statistical significant difference (P<0.01). [157] 
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4.3.3 Brush border enzyme specific activity 
Figure 5 | Brush border enzyme specific activities of co-culture subjected to ST, IN and EX medium change 
protocols at different post-confluence days. ALP (A), APN (B) and DPP IV (C) specific activity were 
determined at each time point. Statistical significative differences among the different protocol mean values, at the 
same post-confluence day, were marked with different symbols (*, § and °). Mean values assumed by one protocol, 
at different time points, were marked with progressive letters when showed a statistical significant difference. The 
level of significance was P<0.01 and P<0.05 only for EX vs IN APN values at T3. [157] 
93 
 
ALP specific activity continuously and significantly increased until T15 for IN and EX groups 
while, in the case of ST, the values increment stopped at T11. EX values of ALP activity were 
always significantly higher than IN and ST ones and, at the same time, ST values were 
constantly lower than IN ones at all post-confluence day, except in the case of T7 (Fig. 5A). A 
similar behaviour was showed by APN of IN and EX values that significantly increased until 
T15. ST values of APN activity showed a significant increase only at T15 and were always 
significantly lower than IN and EX ones, except for IN vs ST at T3. EX values significantly 
differed from IN only at T3 and T7 but not at T11 and T15 where displayed similar values (Fig. 
5B). DPP IV activity values significantly increased until T15 for each protocol but, differently 
from ALP and APN, at each time point the ST values were the highest while the EX ones the 
lowest (Fig. 5C). Significative differences among groups at the same time point or for one 
protocol with days in culture showed the following level of significance: P<0.01 and P<0.05 
only for EX vs IN APN values at T3. 
4.3.4 Permeability characteristics  
Normalized TEER values significantly decreased at T7 for ST and IN group, followed by a 
return to T3 values for ST, while in the case of IN values remain stable until T15. EX values 
slightly decreased until T11 followed by a significantly value increase at T15 (P<0.05, Fig. 
6A). LY Papp values significantly increased at T15 for EX and ST group; at this time point EX 
showed the highest permeability values (P<0.01, Fig. 6B). 
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Figure 6 | Permeability features of co-culture subjected to ST, IN and EX medium change protocols at 
different post-confluence days. Normalized TEER (A) and LY Papp (B) were determined at each time point; data 
were normalized as described in paragraph 4.2.6. Statistical significative differences among the different protocol 
mean values, at the same post-confluence day, were marked with different symbols (* and °). Mean values assumed 
by one protocol, at different time points, were marked with progressive letters when showed a statistical significant 
difference. The TEER and LY Papp level of significance was respectively P<0.05 and P<0.01. [157] 
4.3.5 ROS and NO intracellular production 
The average daily ROS production remained constant until T11 and significantly rose only at 
T15 for each medium change protocols (P<0.01 for EX and P<0.05 for IN and ST). EX 
assumed, at each post-confluence days, the highest values while ST the lowest ones. At the 
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same time, IN assumed values similar to ST ones but they were always significantly different 
from both ST and EX (P<0.01, Fig. 7A).   
Figure 7 | Oxidative status of co-culture subjected to ST, IN and EX medium change protocols at different 
post-confluence days. Averaged daily ROS (A) and NO (B) production was determined at each time point; data 
were normalized as described in paragraph 4.2.10. Statistical significative differences among the different 
protocol mean values, at the same post-confluence day, were marked with different symbols (*, ° and §). Mean 
values assumed by one protocol, at different time points, were marked with progressive letters when showed a 
statistical significant difference. The ROS level of significance was P<0.01 and P<0.05 only for IN and ST with 
days in culture, while for NO production the level of significance was P<0.01 and P<0.05 only for IN at T7 vs 
T11. [157] 
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An opposite behaviour was observed for the average daily production of NO, in fact each group 
showed the highest values at T3. In the case of ST, values remained constant from T7 to T15, 
while NO production significantly increased again at T15 for EX and IN. At each time point, 
EX values were always higher than ST and IN; at the same time ST values were always lower 
than IN ones (P<0.01 and P<0.05 only for IN at T7 vs T11, Fig. 7B). 
4.3.6 Cytokines and PYY production 
IL-6 production of each protocol remained constant for all the post-confluence days. EX 
assumed at each time point the highest values, while IN and ST values significantly differed 
only at T3 and T15 (Fig. 8A). In the case of IL-8 production, a significative increase was 
observed for each protocol only at T15. At this time point EX value was the highest, while ST 
value was the lowest (Fig. 8B). The level of significance was always P<0.01 and P<0.05 only 
between IN and EX at T11 for both IL-6 and IL-8. Finally, PYY production was always the 
highest for EX at each time point, while IN and ST significantly differed only at T11 and T15 
(P<0.01, Fig. 8C). 
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Figure 8 | Inflammation degree and PYY production of co-culture subjected to ST, IN and EX medium 
change protocols at different post-confluence days. Averaged daily IL-6 (A), IL-8 (B) and PYY (C) production 
was determined at each time point; data were normalized as described in paragraph 4.2.10. Statistical significative 
differences among the different protocol mean values, at the same post-confluence day, were marked with different 
symbols (*, ° and §). Mean values assumed by one protocol, at different time points, were marked with progressive 
letters when showed a statistical significant difference. The IL-6, IL-8 and PYY level of significance was always 
P<0.01 and P<0.05 only between IN and EX at T11 for both IL-6 and IL-8. [157] 
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4.4 DISCUSSION 
Several studies have shown that the morpho-functional characteristics and the differentiation 
pathways of in vitro intestinal cell models may be modified by the type of growth medium, the 
presence of specific nutrients such as glucose, glutamine and FBS, the growth support, the 
presence of differentiation inducers and other factors [9, 94]. However, no studies have 
investigated the effect that the administration of different amounts of culture medium can 
induce on the morpho-functional characteristics of the considered in vitro intestinal cell model, 
especially in the case of already differentiated cells. On the other hand, there are many 
experimental evidences that correlate the introduction of an excess of nutrients with the diet to 
profound modifications of the in vivo intestinal epithelium features [72-77, 79-89] as well as 
the onset of a local inflammatory process and an oxidative status [90-92]. 
Therefore, the aim of this study was to investigate for the first time in an in vitro human 
intestinal cell model, the effect of a nutrient excess on its morphological and functional features 
increasing the medium change frequency. EX protocol induced a rapidly and more pronounced 
increased of both the living cell number and protein content with days in culture than the ST 
protocol. Interesting, in the case of EX the number of living cells at T15 dropped to IN values 
probably because the cell growth area was insufficient to further proliferation. This decrease 
was not found for the protein content thus indicating that cells were in any case active in the 
increase of their mass, as revealed by the pellet weight collected for the enzymatic assays (data 
not showed). Hence, co-culture seemed to be able to respond to nutrient excess in a manner 
similar to that of the in vivo intestinal epithelium [73-78] with the difference that the cells in 
active proliferation were not stem cells but well-differentiated cells towards the intestinal 
phenotype (enterocytes and mucus-secreting cells). Considering the morphological features, the 
ST arrangement in a multilayer, that became more evident in IN and EX group, was just 
evidenced in previous published studies [5, 13, 28, 95]. At the same time, the absence of mucus-
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secreting cells together with the important increment in microvilli density and length in the ST 
condition at T15 was indicative of a prevalent absorptive phenotype, as just previously revealed 
[95]. On the contrary, at this time point, co-culture subjected to an excess of nutrients showed 
an important decrease in the number of apical microvilli which seemed to not correlate with the 
continuously and more pronounced increase of ALP and APN specific activity with days in 
culture. Indeed, this continuously increase of EX enzymatic activity was correlated to the 
elevated presence of FLS containing functional microvilli at T15. Another factor involved in 
ALP and APN activity behavior was the higher amount of specific enzymatic substrates 
provided by the frequent medium change in EX protocol. This finding agrees with in vivo 
studies [79-82, 86]. In the case of DPP IV, the excess of nutrients was correlated again with an 
increased activity, but the values were always lower than in IN and ST conditions. This trend 
could be correlated to the increasing cell exposure to Met, Leu and Trp, known inhibitors of the 
DPP IV activity, due to the elevated frequency of medium change in EX protocol, although 
without reaching a suppression as in in vivo experiments [83, 84]. Another important 
modification caused by nutrient excess was the pronounced permeability increase, as showed 
by LY Papp values at T15, which was correlated with the paracellular junctional apparatus 
disappearance instead of a different TJ proteins modulation as revealed by in vivo experiments 
[88, 89]. Some studies in literature have shown that Caco2 and HT-29 cell lines are able to 
increase both the production and the secretion of inflammatory cytokines following exposure 
to inflammatory stimuli, such as a bacterial invasion or exposure to other inflammatory 
cytokines (TNF-α and IL-1)[160-162]. Moreover, recent studies have shown that in vivo the 
excess of specific intestinal nutrients, particularly fats, is able to induce the onset of an 
inflammatory response caused by the production of pro-inflammatory cytokines by the small 
intestinal epithelium, such as IL-8, IL-6 and TNF-α, and an oxidative status [90-92]. The 
exposure to higher quantity of nutrients in EX condition in our co-culture induced an elevated 
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degree of inflammation and oxidative status, as revealed by IL-6, IL-8, ROS and NO production 
that assumed, at all the post-confluence days, the highest values.  
The application of the IN protocol induced morpho-functional adaptations far from the ones 
obtained for EX protocol and in the case of ROS, NO and cytokines production results were 
more similar to ST group than EX ones. Furthermore, some morphological observations were 
transient and not stable with days in culture, such as the elevated FLS presence at T11 that 
disappeared at the next time point as well as the disappearance of cell junctions at T11 while 
were present in elevated quantity at T7 and T15. These observations together with the long time 
in post-confluence needed to obtain, in EX condition, morphological and functional 
modifications comparable to the in vivo observed ones, revealed that the intestinal adaptation 
to nutrient excess required a continuously presence of high nutrient amount for a long time. 
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Chapter 5 
General Conclusion 
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The morpho-functional characteristics of the so far developed 70/30 co-culture progressively 
changed with time in culture and shifted towards the absorptive phenotype. This versatility give 
the opportunity to use the 70/30 co-culture at different cell differentiation degrees depending 
on the features needed for a specific experiment.  At T6, the contemporary presence of a 
complete junctional apparatus, mucus and permeability values comparable to the in vivo ones, 
made this co-culture suitable for studying drug/nutrient absorption and interactions. At the same 
time, the absence of mucus and the higher presence of microvilli with active hydrolases at T14 
suggested a model for food digestion studies. Furthermore, the reduced time needed to reach 
the right degree of cell differentiation, associated with a cheaper and simpler methodology, 
made this model most suitable to mimic the human intestinal epithelium than the previous 
published ones. To the completeness of the study, the use of water biscuits and bread digestates 
showed the suitability of the 70/30 co-culture to study a wide range of interactions between 
nutrient/food/nutraceuticals and intestine. In addition, these two studies pointed out the 
necessity to test the potential biological activity and toxicity of a compound present in food or 
a nutraceutical using an in vitro procedure based on specific and essential steps. First, it is 
fundamental to evaluate the bioaccessibility, bioavailability and the possible modifications of 
the compound or nutrient of interest due to the gastrointestinal digestion. Second, the bioactivity 
must be evaluated in an in vitro intestinal model, with morpho-functional characteristics 
comparable to the human ones, instead of test tube assays. Finally, digestates must be tested at 
doses comparable to the physiological quantity that comes into contact with a specific area of 
our intestine after a food serving size consumption.  
The 70/30 co-culture was finally used to demonstrate for the first time in vitro that the presence 
of high amounts of nutrients can profoundly modify the morpho-functional characteristics of 
intestinal cells, already differentiated, inducing adaptations similar to the ones reported by in 
vivo studies and related to the developing of an obese/overweigh phenotype. As a consequence, 
the co-culture model exposed to the EX protocol of medium change could be useful to study 
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the molecular and biochemical pathways at the base of the obese/overweight intestine. The 
associate outcome of this last part of the project was the comprehension that the frequency of 
culture medium administration was able to profoundly modify the morphological and functional 
characteristics of the in vitro intestinal cell model used and, as a consequence, to strongly 
influence the final result of an experiment. 
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